Tandem	B-DNA
AP-1-binding	I-DNA
sites	I-DNA
within	O
the	O
human	B-DNA
beta-globin	I-DNA
dominant	I-DNA
control	I-DNA
region	I-DNA
function	O
as	O
an	O
inducible	B-DNA
enhancer	I-DNA
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

A	O
powerful	O
enhancer	O
has	O
been	O
mapped	O
to	O
an	O
18-bp	B-DNA
DNA	I-DNA
segment	I-DNA
located	O
11	O
kb	O
5	O
'	O
to	O
the	O
human	B-DNA
epsilon-globin	I-DNA
gene	I-DNA
within	O
the	O
dominant	B-DNA
control	I-DNA
or	O
locus-activating	B-DNA
region	I-DNA
.	O

This	O
enhancer	B-DNA
is	O
inducible	O
in	O
K562	B-cell_line
human	I-cell_line
erythroleukemia	I-cell_line
cells	I-cell_line
,	O
increasing	O
linked	O
gamma-globin	B-DNA
promoter	I-DNA
/luciferase	B-protein
gene	O
expression	O
to	O
170-fold	O
over	O
an	O
enhancerless	B-DNA
construct	I-DNA
.	O

The	O
enhancer	B-DNA
consists	O
of	O
tandem	B-DNA
AP-1-binding	I-DNA
sites	I-DNA
,	O
phased	O
10	O
bp	O
apart	O
,	O
which	O
are	O
both	O
required	O
for	O
full	O
activity	O
.	O

DNA-protein	O
binding	O
assays	O
with	O
nuclear	O
extracts	O
from	O
induced	O
cells	O
demonstrate	O
a	O
high	B-protein
molecular	I-protein
weight	I-protein
complex	I-protein
on	O
the	O
enhancer	B-DNA
.	O

The	O
formation	O
of	O
this	O
complex	O
also	O
requires	O
both	O
AP-1	B-DNA
sites	I-DNA
and	O
correlates	O
with	O
maximal	O
enhancer	B-DNA
activity	O
.	O

Induction	O
of	O
the	O
enhancer	B-DNA
may	O
have	O
a	O
role	O
in	O
the	O
increase	O
in	O
globin	B-DNA
gene	I-DNA
transcription	O
that	O
characterizes	O
erythroid	O
maturation	O
.	O

Enhancer	O
activity	O
appears	O
to	O
be	O
mediated	O
by	O
the	O
binding	O
of	O
a	O
complex	O
of	O
proteins	O
from	O
the	O
jun	B-DNA
and	I-DNA
fos	I-DNA
families	I-DNA
to	O
tandem	B-DNA
AP-1	I-DNA
consensus	I-DNA
sequences	I-DNA
.	O

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Tandem	NULL
AP-1-binding	NULL
sites	NULL
within	NULL
the	NULL
human	NULL
B-globin	NULL
dominant	NULL
control	NULL
region	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
enhancer	NULL
in	NULL
erythroid	NULL
cells	NULL
Paul	NULL
A.	NULL
Ney	NULL
,	NULL
Brian	NULL
P.	NULL
Sorrentino	NULL
,	NULL
Kevin	NULL
T.	NULL
McDonagh	NULL
,	NULL
and	NULL
Arthur	NULL
W.	NULL
Nienhuis	NULL
Clinical	NULL
Hematology	NULL
Branch	NULL
,	NULL
National	NULL
Heart	NULL
,	NULL
Lung	NULL
,	NULL
and	NULL
Blood	NULL
Institute	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892	NULL
USA	NULL
A	NULL
powerful	NULL
enhancer	NULL
has	NULL
been	NULL
mapped	NULL
to	NULL
an	NULL
18-bp	NULL
DNA	NULL
segment	NULL
located	NULL
11	NULL
kb	NULL
5	NULL
'	NULL
to	NULL
the	NULL
human	NULL
e-globin	NULL
gene	NULL
within	NULL
the	NULL
dominant	NULL
control	NULL
or	NULL
locus-activating	NULL
region	NULL
.	NULL

This	NULL
enhancer	NULL
is	NULL
inducible	NULL
in	NULL
K562	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
,	NULL
increasing	NULL
linked	NULL
y-globin	NULL
promoter/luciferase	NULL
gene	NULL
expression	NULL
to	NULL
170-fold	NULL
over	NULL
an	NULL
enhancerless	NULL
construct	NULL
.	NULL

The	NULL
enhancer	NULL
consists	NULL
of	NULL
tandem	NULL
AP-1	NULL
-binding	NULL
sites	NULL
,	NULL
phased	NULL
10	NULL
bp	NULL
apart	NULL
,	NULL
which	NULL
are	NULL
both	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
.	NULL

DNA-protein	NULL
binding	NULL
assays	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
induced	NULL
cells	NULL
demonstrate	NULL
a	NULL
high	NULL
molecular	NULL
weight	NULL
complex	NULL
on	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
also	NULL
requires	NULL
both	NULL
AP-1	NULL
sites	NULL
and	NULL
correlates	NULL
with	NULL
maximal	NULL
enhancer	NULL
activity	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
enhancer	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
increase	NULL
in	NULL
globin	NULL
gene	NULL
transcription	NULL
that	NULL
characterizes	NULL
erythroid	NULL
maturation	NULL
.	NULL

Enhancer	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
a	NULL
complex	NULL
of	NULL
proteins	NULL
from	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
to	NULL
tandem	NULL
AP-1	NULL
consensus	NULL
sequences	NULL
.	NULL

[	NULL
Key	NULL
Words	NULL
:	NULL
AP-1	NULL
;	NULL
erythroid	NULL
;	NULL
inducible	NULL
;	NULL
enhancer	NULL
;	NULL
DCR	NULL
;	NULL
hypersensitive	NULL
site	NULL
]	NULL
Received	NULL
October	NULL
5	NULL
,	NULL
1989	NULL
;	NULL
revised	NULL
version	NULL
accepted	NULL
March	NULL
13	NULL
,	NULL
1990	NULL
.	NULL

Human	NULL
hemoglobins	NULL
are	NULL
tetramers	NULL
composed	NULL
of	NULL
two	NULL
pairs	NULL
of	NULL
globins	NULL
,	NULL
with	NULL
one	NULL
pair	NULL
encoded	NULL
by	NULL
a	NULL
gene	NULL
within	NULL
the	NULL
«	NULL
-like	NULL
cluster	NULL
on	NULL
chromosome	NULL
16	NULL
and	NULL
the	NULL
other	NULL
pair	NULL
encoded	NULL
by	NULL
a	NULL
gene	NULL
within	NULL
the	NULL
B-like	NULL
cluster	NULL
on	NULL
chromosome	NULL
11	NULL
.	NULL

The	NULL
B-gene	NULL
cluster	NULL
contains	NULL
five	NULL
functional	NULL
genes	NULL
and	NULL
one	NULL
pseudogene	NULL
{	NULL
(	NULL
e	NULL
,	NULL
%	NULL
y	NULL
,	NULL
*y	NULL
,	NULL
-B	NULL
,	NULL
8	NULL
,	NULL
and	NULL
B	NULL
)	NULL
that	NULL
are	NULL
distributed	NULL
over	NULL
40	NULL
kb	NULL
of	NULL
DNA	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
B-like	NULL
globin	NULL
genes	NULL
is	NULL
both	NULL
tissue	NULL
and	NULL
developmentally	NULL
stage	NULL
specific	NULL
.	NULL

e-	NULL
,	NULL
y-	NULL
,	NULL
and	NULL
B-globins	NULL
are	NULL
produced	NULL
in	NULL
em-bryonic	NULL
,	NULL
fetal	NULL
,	NULL
and	NULL
adult	NULL
erythroid	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

Globin	NULL
genes	NULL
at	NULL
each	NULL
developmental	NULL
stage	NULL
exhibit	NULL
a	NULL
marked	NULL
increase	NULL
in	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
during	NULL
maturation	NULL
of	NULL
erythroid	NULL
cells	NULL
in	NULL
contrast	NULL
to	NULL
diminished	NULL
expression	NULL
of	NULL
most	NULL
other	NULL
genes	NULL
(	NULL
Karlsson	NULL
and	NULL
Nienhuis	NULL
1985	NULL
;	NULL
Stamatoyannopoulos	NULL
and	NULL
Nienhuis	NULL
1987	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
genes	NULL
within	NULL
the	NULL
B-cluster	NULL
occurs	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
through	NULL
interaction	NULL
of	NULL
trans-acting	NULL
proteins	NULL
with	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
(	NULL
Dynan	NULL
1989	NULL
;	NULL
Mitchell	NULL
and	NULL
Tjian	NULL
1989	NULL
)	NULL
.	NULL

The	NULL
promoters	NULL
of	NULL
the	NULL
individual	NULL
globin	NULL
genes	NULL
are	NULL
tissue	NULL
specific	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
preferential	NULL
expression	NULL
during	NULL
development	NULL
(	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
;	NULL
Rutherford	NULL
and	NULL
Nienhuis	NULL
1987	NULL
)	NULL
.	NULL

Intra-genic	NULL
elements	NULL
and	NULL
enhancers	NULL
3	NULL
'	NULL
to	NULL
the	NULL
B	NULL
and	NULL
*y	NULL
genes	NULL
may	NULL
also	NULL
provide	NULL
specificity	NULL
(	NULL
Behringer	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
;	NULL
Bodine	NULL
and	NULL
Ley	NULL
1987	NULL
;	NULL
Kollias	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
;	NULL
Trudel	NULL
and	NULL
Cos-tantini	NULL
1987	NULL
;	NULL
Antoniou	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

The	NULL
promoters	NULL
and	NULL
enhancers	NULL
are	NULL
marked	NULL
by	NULL
tissue-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
as	NULL
assayed	NULL
in	NULL
isolated	NULL
nuclei	NULL
.	NULL

Formation	NULL
of	NULL
such	NULL
sites	NULL
at	NULL
the	NULL
promoters	NULL
is	NULL
developmentally	NULL
stage	NULL
specific	NULL
(	NULL
Groudine	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
;	NULL
Tuan	NULL
and	NULL
London	NULL
1984	NULL
)	NULL
.	NULL

Several	NULL
proteins	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
sequence	NULL
motifs	NULL
within	NULL
globin	NULL
promoters	NULL
and	NULL
enhancers	NULL
{	NULL
de	NULL
Boer	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Gumucio	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Mantovani	NULL
et	NULL
al	NULL
.	NULL

1988a	NULL
,	NULL
b	NULL
;	NULL
Catala	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
,	NULL
including	NULL
one	NULL
such	NULL
factor	NULL
found	NULL
only	NULL
in	NULL
erythroid	NULL
cells	NULL
,	NULL
designated	NULL
nuclear	NULL
factor-erythroid	NULL
1	NULL
(	NULL
NE-E1	NULL
)	NULL
or	NULL
globin	NULL
factor-1	NULL
(	NULL
GF-1	NULL
)	NULL
(	NULL
Wall	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Study	NULL
of	NULL
naturally	NULL
occurring	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
B-globin	NULL
cluster	NULL
,	NULL
the	NULL
(	NULL
y8B	NULL
)	NULL
-thalassemias	NULL
,	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
additional	NULL
regulatory	NULL
elements	NULL
.	NULL

An	NULL
intact	NULL
B-globin	NULL
gene	NULL
on	NULL
a	NULL
chromosome	NULL
with	NULL
a	NULL
large	NULL
upstream	NULL
deletion	NULL
was	NULL
unexpressed	NULL
,	NULL
methylated	NULL
,	NULL
and	NULL
in	NULL
an	NULL
inactive	NULL
chromatin	NULL
conformation	NULL
(	NULL
Kioussis	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
)	NULL
.	NULL

Major	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
have	NULL
been	NULL
discovered	NULL
5	NULL
'	NULL
and	NULL
3	NULL
'	NULL
to	NULL
the	NULL
B-globin	NULL
gene	NULL
cluster	NULL
,	NULL
identifying	NULL
regions	NULL
that	NULL
may	NULL
contain	NULL
these	NULL
regulatory	NULL
elements	NULL
(	NULL
Tuan	NULL
and	NULL
London	NULL
1984	NULL
;	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

1985	NULL
;	NULL
Forrester	NULL
et	NULL
al	NULL
,	NULL
1986	NULL
)	NULL
.	NULL

Four	NULL
erythroid-specific	NULL
hypersensitive	NULL
sites	NULL
(	NULL
HS	NULL
I-HS	NULL
IV	NULL
)	NULL
,	NULL
distributed	NULL
over	NULL
20	NULL
kb	NULL
,	NULL
5¢	NULL
to	NULL
the	NULL
e-globin	NULL
gene	NULL
,	NULL
are	NULL
present	NULL
in	NULL
nuclear	NULL
chromatin	NULL
from	NULL
erythroid	NULL
cells	NULL
of	NULL
all	NULL
developmental	NULL
stages	NULL
.	NULL

A	NULL
fifth	NULL
site	NULL
located	NULL
even	NULL
farther	NULL
5	NULL
!	NULL

to	NULL
the	NULL
e	NULL
gene	NULL
is	NULL
also	NULL
present	NULL
in	NULL
other	NULL
hematopoietic	NULL
cells	NULL
.	NULL

The	NULL
sixth	NULL
site	NULL
(	NULL
HS	NULL
VIJ	NULL
is	NULL
located	NULL
21.8	NULL
kb	NULL
3	NULL
'	NULL
to	NULL
the	NULL
B-globin	NULL
gene	NULL
.	NULL

Other	NULL
(	NULL
y8B	NULL
)	NULL
-thalassemia	NULL
mutations	NULL
have	NULL
been	NULL
characterized	NULL
(	NULL
Curtin	NULL
et	NULL
al	NULL
.	NULL

1985	NULL
)	NULL
,	NULL
including	NULL
one	NULL
that	NULL
begins	NULL
between	NULL
HS	NULL
I	NULL
and	NULL
HS	NULL
II	NULL
,	NULL
9.5	NULL
kb	NULL
5	NULL
to	NULL
the	NULL
e	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
4:993-1006	NULL
©	NULL
1990	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
ISSN	NULL
0890-9369/90	NULL
$	NULL
1.00	NULL
993	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

gene	NULL
,	NULL
leaving	NULL
HS	NULL
I	NULL
and	NULL
the	NULL
entire	NULL
cluster	NULL
intact	NULL
(	NULL
Driscoll	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
]	NULL
.	NULL

The	NULL
B	NULL
gene	NULL
on	NULL
this	NULL
chromosome	NULL
was	NULL
not	NULL
expressed	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
flanking	NULL
HS	NULL
sites	NULL
,	NULL
particularly	NULL
those	NULL
5	NULL
'	NULL
to	NULL
the	NULL
cluster	NULL
,	NULL
have	NULL
emerged	NULL
as	NULL
potential	NULL
regulatory	NULL
elements	NULL
that	NULL
may	NULL
control	NULL
expression	NULL
of	NULL
the	NULL
entire	NULL
gene	NULL
cluster	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Direct	NULL
experimental	NULL
evidence	NULL
for	NULL
an	NULL
important	NULL
functional	NULL
role	NULL
of	NULL
these	NULL
regulatory	NULL
elements	NULL
was	NULL
obtained	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

In	NULL
earlier	NULL
studies	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
was	NULL
expressed	NULL
at	NULL
low	NULL
levels	NULL
in	NULL
transgenic	NULL
animals	NULL
with	NULL
substantial	NULL
variation	NULL
among	NULL
strains	NULL
derived	NULL
from	NULL
different	NULL
founder	NULL
animals	NULL
(	NULL
Magram	NULL
et	NULL
al	NULL
.	NULL

1985	NULL
;	NULL
Townes	NULL
et	NULL
al	NULL
.	NULL

1985	NULL
;	NULL
Kollias	NULL
et	NULL
al	NULL
.	NULL

1986	NULL
)	NULL
.	NULL

Grosveld	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
assembled	NULL
a	NULL
38-kb	NULL
segment	NULL
of	NULL
DNA	NULL
that	NULL
included	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
flanked	NULL
by	NULL
fragments	NULL
containing	NULL
the	NULL
5	NULL
and	NULL
3	NULL
'	NULL
major	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
.	NULL

Within	NULL
the	NULL
context	NULL
of	NULL
these	NULL
regulatory	NULL
elements	NULL
,	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
was	NULL
expressed	NULL
at	NULL
a	NULL
high	NULL
level	NULL
,	NULL
equivalent	NULL
to	NULL
that	NULL
of	NULL
an	NULL
endogenous	NULL
mouse	NULL
gene	NULL
,	NULL
and	NULL
independent	NULL
of	NULL
chromosomal	NULL
integration	NULL
position	NULL
.	NULL

Because	NULL
of	NULL
its	NULL
activity	NULL
in	NULL
transgenic	NULL
mice	NULL
and	NULL
ability	NULL
to	NULL
confer	NULL
erythroid	NULL
specificity	NULL
on	NULL
heterologous	NULL
promoters	NULL
,	NULL
Grosveld	NULL
and	NULL
his	NULL
colleagues	NULL
designated	NULL
the	NULL
5	NULL
'	NULL
region	NULL
containing	NULL
major	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
as	NULL
the	NULL
dominant	NULL
control	NULL
region	NULL
(	NULL
DCR	NULL
)	NULL
(	NULL
Blom	NULL
van	NULL
Assendelft	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
;	NULL
Talbot	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

An	NULL
alternative	NULL
designation	NULL
,	NULL
that	NULL
of	NULL
the	NULL
locus-activating	NULL
region	NULL
(	NULL
LAR	NULL
)	NULL
,	NULL
is	NULL
based	NULL
on	NULL
the	NULL
apparent	NULL
ability	NULL
of	NULL
regulatory	NULL
elements	NULL
within	NULL
this	NULL
region	NULL
to	NULL
establish	NULL
an	NULL
active	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
cluster	NULL
(	NULL
Forrester	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

Progress	NULL
has	NULL
been	NULL
made	NULL
in	NULL
localizing	NULL
the	NULL
functional	NULL
components	NULL
within	NULL
the	NULL
DCR/LAR	NULL
,	NULL
although	NULL
the	NULL
sequence	NULL
motifs	NULL
and	NULL
interacting	NULL
proteins	NULL
required	NULL
for	NULL
DCR/LAR	NULL
activity	NULL
have	NULL
not	NULL
yet	NULL
been	NULL
defined	NULL
.	NULL

A	NULL
6.5-kb	NULL
fragment	NULL
containing	NULL
the	NULL
four	NULL
erythroid-specific	NULL
5°	NULL
HS	NULL
sites	NULL
has	NULL
full	NULL
activity	NULL
in	NULL
both	NULL
transgenic	NULL
mice	NULL
and	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
cells	NULL
(	NULL
Talbot	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Forrester	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
have	NULL
demonstrated	NULL
that	NULL
a	NULL
2.5-kb	NULL
fragment	NULL
containing	NULL
these	NULL
sites	NULL
also	NULL
has	NULL
full	NULL
DCR/LAR	NULL
activity	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

A	NULL
fragment	NULL
containing	NULL
only	NULL
HS	NULL
II	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
confer	NULL
tissue-specific	NULL
,	NULL
high-level	NULL
expression	NULL
on	NULL
a	NULL
-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
at	NULL
40-50	NULL
%	NULL
the	NULL
level	NULL
achieved	NULL
with	NULL
all	NULL
four	NULL
sites	NULL
(	NULL
Ryan	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
HS	NULL
II	NULL
contains	NULL
a	NULL
powerful	NULL
enhancer	NULL
,	NULL
active	NULL
in	NULL
transient	NULL
assays	NULL
performed	NULL
with	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
(	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
this	NULL
enhancer	NULL
is	NULL
an	NULL
important	NULL
regulatory	NULL
el-	NULL
Figure	NULL
1	NULL
.	NULL

Position	NULL
of	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
flanking	NULL
the	NULL
human	NULL
B-like	NULL
gene	NULL
cluster	NULL
.	NULL

The	NULL
five	NULL
functional	NULL
genes	NULL
of	NULL
the	NULL
human	NULL
B-like	NULL
gene	NULL
cluster	NULL
,	NULL
distributed	NULL
over	NULL
~40	NULL
kb	NULL
,	NULL
are	NULL
shown	NULL
.	NULL

Four	NULL
developmentally	NULL
stable	NULL
erythroid-specific	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
are	NULL
located	NULL
5°	NULL
and	NULL
one	NULL
3	NULL
'	NULL
of	NULL
the	NULL
cluster	NULL
.	NULL

We	NULL
have	NULL
used	NULL
the	NULL
nomenclature	NULL
of	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
.	NULL

Distance	NULL
in	NULL
kilo-bases	NULL
from	NULL
the	NULL
e-globin	NULL
gene	NULL
(	NULL
HS	NULL
I-HS	NULL
IV	NULL
)	NULL
or	NULL
the	NULL
B-globin	NULL
gene	NULL
{	NULL
HS	NULL
VI	NULL
)	NULL
is	NULL
given	NULL
in	NULL
parentheses	NULL
.	NULL

HS	NULL
V	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
is	NULL
not	NULL
erythroid	NULL
specific	NULL
.	NULL

The	NULL
1455-bp	NULL
HS	NULL
II-con-taining	NULL
fragment	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
is	NULL
expanded	NULL
to	NULL
show	NULL
the	NULL
relative	NULL
position	NULL
of	NULL
several	NULL
restriction	NULL
sites	NULL
.	NULL

Kpol	NULL
{	NULL
-	NULL
11.8	NULL
)	NULL
994	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
+	NULL
(	NULL
-	NULL
14.7	NULL
)	NULL
HSIV	NULL
(	NULL
-18.0	NULL
}	NULL
ement	NULL
within	NULL
the	NULL
DCR/LAR	NULL
.	NULL

We	NULL
have	NULL
now	NULL
mapped	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
to	NULL
an	NULL
18-bp	NULL
segment	NULL
.	NULL

Its	NULL
activity	NULL
increases	NULL
with	NULL
induction	NULL
of	NULL
erythroid	NULL
maturation	NULL
in	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
and	NULL
depends	NULL
on	NULL
interaction	NULL
with	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
tandem	NULL
AP-1	NULL
consensus	NULL
sequences	NULL
within	NULL
the	NULL
18-bp	NULL
element	NULL
.	NULL

Results	NULL
Localization	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
The	NULL
distribution	NULL
of	NULL
the	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
5	NULL
'	NULL
to	NULL
the	NULL
e-globin	NULL
gene	NULL
that	NULL
mark	NULL
the	NULL
DCR	NULL
are	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

HS	NULL
II	NULL
has	NULL
been	NULL
localized	NULL
to	NULL
10.9	NULL
kb	NULL
{	NULL
+	NULL
0.1	NULL
kb	NULL
)	NULL
5	NULL
!	NULL

to	NULL
the	NULL
e-globin	NULL
gene	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
Forrester	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

In	NULL
mapping	NULL
the	NULL
enhancer	NULL
,	NULL
we	NULL
initiated	NULL
our	NULL
studies	NULL
with	NULL
a	NULL
1455-bp	NULL
KpnI-Bgill	NULL
fragment	NULL
containing	NULL
HS	NULL
II	NULL
.	NULL

We	NULL
designated	NULL
the	NULL
first	NULL
nucleotide	NULL
within	NULL
the	NULL
Kpzal	NULL
site	NULL
as	NULL
nucleotide	NULL
1	NULL
,	NULL
making	NULL
the	NULL
first	NULL
nucleotide	NULL
within	NULL
the	NULL
BgllI	NULL
site	NULL
nucleotide	NULL
1455	NULL
.	NULL

A	NULL
732-bp	NULL
HindllI-Bglll	NULL
fragment	NULL
{	NULL
nucleotide	NULL
723-1455	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
the	NULL
enhancing	NULL
activity	NULL
of	NULL
HS	NULL
II	NULL
(	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

We	NULL
utilized	NULL
a	NULL
larger	NULL
KpnI-Bglll	NULL
fragment	NULL
to	NULL
include	NULL
another	NULL
hypersensitive	NULL
site	NULL
present	NULL
in	NULL
nuclei	NULL
of	NULL
erythroleukemia	NULL
cells	NULL
(	NULL
Forrester	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

Our	NULL
reporter	NULL
plasmid	NULL
consisted	NULL
of	NULL
a	NULL
-260	NULL
y-globin	NULL
gene	NULL
promoter	NULL
,	NULL
in	NULL
a	NULL
pUC-based	NULL
plasmid	NULL
,	NULL
linked	NULL
5	NULL
'	NULL
to	NULL
the	NULL
coding	NULL
sequence	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
DeWet	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

Mutants	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
fragment	NULL
or	NULL
oligonucleotides	NULL
were	NULL
subcloned	NULL
5	NULL
of	NULL
the	NULL
chimeric	NULL
y-globin	NULL
promoter/luciferase	NULL
gene	NULL
and	NULL
assayed	NULL
for	NULL
enhancing	NULL
activity	NULL
.	NULL

Transient	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
(	NULL
Lozzio	NULL
and	NULL
Lozzio	NULL
1975	NULL
)	NULL
.	NULL

K562	NULL
cells	NULL
express	NULL
the	NULL
e-	NULL
and	NULL
y-globin	NULL
,	NULL
but	NULL
not	NULL
B-globin	NULL
genes	NULL
and	NULL
therefore	NULL
have	NULL
been	NULL
used	NULL
as	NULL
a	NULL
model	NULL
for	NULL
the	NULL
embryonic/fetal	NULL
stage	NULL
of	NULL
development	NULL
(	NULL
Rutherford	NULL
et	NULL
al	NULL
.	NULL

1981	NULL
;	NULL
Dean	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
chemicals	NULL
such	NULL
as	NULL
hemin	NULL
to	NULL
K562	NULL
cells	NULL
induces	NULL
an	NULL
erythroid	NULL
phenotype	NULL
,	NULL
as	NULL
manifested	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
globin	NULL
and	NULL
other	NULL
erythroid-specific	NULL
genes	NULL
[	NULL
HMoffman	NULL
et	NULL
al	NULL
.	NULL

1980	NULL
;	NULL
Dean	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
;	NULL
McGinniss	NULL
and	NULL
Dean	NULL
1985	NULL
;	NULL
Bartha	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

The	NULL
5	NULL
)	NULL
and	NULL
3	NULL
``	NULL
truncation	NULL
mutants	NULL
of	NULL
the	NULL
HSI	NULL
fragment	NULL
were	NULL
made	NULL
by	NULL
exonuclease	NULL
III	NULL
digestion	NULL
.	NULL

These	NULL
mutants	NULL
were	NULL
cotransfected	NULL
into	NULL
K562	NULL
cells	NULL
with	NULL
a	NULL
B19	NULL
promoter/	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
B19-CAT	NULL
)	NULL
reporter	NULL
construct	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

Relative	NULL
activity	NULL
was	NULL
derived	NULL
by	NULL
dividing	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
a	NULL
given	NULL
mu	NULL
HSHL	NULL
HSH	NULL
(	NULL
~6.1	NULL
)	NULL
HSH	NULL
t	NULL
(	NULL
-10.9	NULL
)	NULL
l	NULL
Hind	NULL
III	NULL
Ball	NULL
Xba	NULL
HSVI	NULL
{	NULL
21.8	NULL
)	NULL
¢	NULL
5	NULL
,	NULL
A	NULL
,	NULL
6	NULL
A	NULL
i	NULL
m-	NULL
-mm	NULL
agill	NULL
(	NULL
-10.3	NULL
)	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
tant	NULL
by	NULL
that	NULL
of	NULL
the	NULL
enhancerless	NULL
reporter	NULL
plasmid	NULL
,	NULL
each	NULL
having	NULL
been	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
with	NULL
the	NULL
internal	NULL
control	NULL
.	NULL

Study	NULL
of	NULL
the	NULL
initial	NULL
set	NULL
of	NULL
truncation	NULL
mutants	NULL
demonstrated	NULL
that	NULL
the	NULL
enhancer	NULL
was	NULL
within	NULL
a	NULL
174-bp	NULL
fragment	NULL
(	NULL
807-981	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

A	NULL
second	NULL
series	NULL
of	NULL
closely	NULL
spaced	NULL
truncation	NULL
mutants	NULL
established	NULL
the	NULL
3	NULL
'	NULL
border	NULL
of	NULL
the	NULL
enhancer	NULL
at	NULL
nucleotide	NULL
916	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
define	NULL
the	NULL
5	NULL
boundary	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
a	NULL
series	NULL
of	NULL
5	NULL
oligonucleotides	NULL
were	NULL
synthesized	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
expression	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Each	NULL
of	NULL
these	NULL
had	NULL
full	NULL
enhancer	NULL
activity	NULL
,	NULL
including	NULL
the	NULL
smallest	NULL
of	NULL
only	NULL
20	NULL
bp	NULL
(	NULL
896-916	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assays	NULL
were	NULL
done	NULL
to	NULL
identify	NULL
regions	NULL
of	NULL
sequence-specific	NULL
,	NULL
DNA-protein	NULL
interactions	NULL
by	NULL
utilizing	NULL
a	NULL
restriction	NULL
fragment	NULL
extending	NULL
from	NULL
nucleotide	NULL
723	NULL
to	NULL
977	NULL
as	NULL
probe	NULL
.	NULL

With	NULL
K562	NULL
nuclear	NULL
extracts	NULL
,	NULL
a	NULL
very	NULL
prominent	NULL
footprint	NULL
was	NULL
present	NULL
on	NULL
both	NULL
strands	NULL
directly	NULL
over	NULL
the	NULL
functionally	NULL
defined	NULL
minimal	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
footprint	NULL
was	NULL
also	NULL
present	NULL
with	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
and	NULL
hemin-induced	NULL
K562	NULL
cells	NULL
gave	NULL
similar	NULL
footprinting	NULL
pat-terns	NULL
;	NULL
however	NULL
,	NULL
the	NULL
footprint	NULL
over	NULL
the	NULL
enhancer	NULL
appeared	NULL
at	NULL
lower	NULL
concentrations	NULL
of	NULL
induced	NULL
nuclear	NULL
extract	NULL
.	NULL

Uninduced	NULL
and	NULL
induced	NULL
K562	NULL
nuclear	NULL
extracts	NULL
were	NULL
standardized	NULL
by	NULL
comparing	NULL
their	NULL
Spl-binding	NULL
activity	NULL
in	NULL
a	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
,	NULL
which	NULL
was	NULL
equivalent	NULL
at	NULL
equivalent	NULL
protein	NULL
concentrations	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

At	NULL
higher	NULL
con	NULL
AP-1	NULL
sites	NULL
in	NULL
DCR	NULL
function	NULL
as	NULL
inducible	NULL
enhancer	NULL
centrations	NULL
of	NULL
K562	NULL
or	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
,	NULL
another	NULL
footprint	NULL
,	NULL
flanked	NULL
by	NULL
sites	NULL
of	NULL
increased	NULL
DNase	NULL
I	NULL
sensi-tivity	NULL
,	NULL
appeared	NULL
from	NULL
~10-30	NULL
bp	NULL
5	NULL
of	NULL
the	NULL
enhancer	NULL
footprint	NULL
.	NULL

However	NULL
,	NULL
this	NULL
region	NULL
and	NULL
other	NULL
sequences	NULL
outside	NULL
the	NULL
minimal	NULL
enhancer	NULL
were	NULL
not	NULL
necessary	NULL
for	NULL
enhancer	NULL
activity	NULL
and	NULL
were	NULL
not	NULL
studied	NULL
further	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
no	NULL
other	NULL
sequences	NULL
within	NULL
the	NULL
KpnI-Bglll	NULL
HS	NULL
II	NULL
fragment	NULL
had	NULL
enhancer	NULL
activity	NULL
,	NULL
we	NULL
scrambled	NULL
31	NULL
nucleotides	NULL
(	NULL
900-931	NULL
)	NULL
while	NULL
leaving	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
fragment	NULL
unaltered	NULL
.	NULL

This	NULL
mutated	NULL
fragment	NULL
was	NULL
designated	NULL
HS	NULL
II	NULL
enh~	NULL
.	NULL

A	NULL
16-bp	NULL
stretch	NULL
of	NULL
the	NULL
20-bp	NULL
enhancer	NULL
[	NULL
901-916	NULL
)	NULL
was	NULL
mutated	NULL
by	NULL
this	NULL
con-struction	NULL
.	NULL

Our	NULL
earlier	NULL
analysis	NULL
of	NULL
3	NULL
'	NULL
truncation	NULL
mutants	NULL
indicated	NULL
that	NULL
sequences	NULL
between	NULL
916	NULL
and	NULL
931	NULL
,	NULL
also	NULL
rearranged	NULL
in	NULL
this	NULL
construction	NULL
,	NULL
had	NULL
no	NULL
role	NULL
in	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
HS	NULL
II	NULL
enh-	NULL
fragment	NULL
had	NULL
no	NULL
activity	NULL
in	NULL
transient	NULL
assays	NULL
in	NULL
K562	NULL
cells	NULL
[	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
footprint	NULL
present	NULL
over	NULL
the	NULL
active	NULL
enhancer	NULL
was	NULL
not	NULL
present	NULL
when	NULL
the	NULL
corresponding	NULL
restriction	NULL
fragment	NULL
from	NULL
HS	NULL
II	NULL
enh-was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

When	NULL
the	NULL
same	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
HeLa	NULL
cells	NULL
,	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
had	NULL
modest	NULL
activity	NULL
(	NULL
relative	NULL
activity	NULL
:	NULL
no	NULL
HS	NULL
II	NULL
,	NULL
1.0	NULL
+	NULL
0.1	NULL
;	NULL
HS	NULL
II	NULL
(	NULL
1455	NULL
bp	NULL
)	NULL
,	NULL
2.8	NULL
+	NULL
0.8	NULL
;	NULL
HS	NULL
II	NULL
(	NULL
46	NULL
bp	NULL
}	NULL
,	NULL
3.9	NULL
+	NULL
0.1	NULL
;	NULL
HS	NULL
II	NULL
enh~	NULL
,	NULL
0.7	NULL
+	NULL
0.1	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
data	NULL
establish	NULL
that	NULL
a	NULL
20-bp	NULL
segment	NULL
(	NULL
896-9216	NULL
)	NULL
has	NULL
the	NULL
full	NULL
enhancing	NULL
activity	NULL
of	NULL
HS	NULL
II	NULL
and	NULL
that	NULL
no	NULL
other	NULL
sequences	NULL
within	NULL
the	NULL
KpnI-BgIlI	NULL
fragment	NULL
contribute	NULL
to	NULL
this	NULL
activity	NULL
.	NULL

Kpn	NULL
Hind	NULL
-	NULL
Bal	NULL
Xba	NULL
Bg	NULL
!	NULL

Relative	NULL
Activity	NULL
1	NULL
HIP	NULL
od	NULL
1	NULL
IDO	NULL
_	NULL
(	NULL
1100	NULL
(	NULL
20	NULL
0	NULL
30	NULL
s	NULL
|__|	NULL
_	NULL
}	NULL
|__	NULL
J-	NULL
144	NULL
5.1	NULL
8.0	NULL
1	NULL
723	NULL
8o7	NULL
981	NULL
1097	NULL
1455	NULL
~via	NULL
-	NULL
14.6	NULL
*	NULL
15.7	NULL
w	NULL
15.4	NULL
_	NULL
17.8	NULL
m—	NULL
15.0	NULL
-one	NULL
-	NULL
1.0	NULL
ﬁ	NULL
12.9	NULL
w	NULL
:	NULL
13.9	NULL
ﬂ	NULL
13.6	NULL
ﬂ	NULL
18.5	NULL
ﬁ-	NULL
0.4	NULL
oman	NULL
-	NULL
0.4	NULL
|	NULL
70	NULL
\o	NULL
lomi	NULL
C	NULL
18.1	NULL
No	NULL
HS	NULL
11	NULL
1.0	NULL
__	NULL
1.0	NULL
1.0	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Enhancing	NULL
activity	NULL
of	NULL
HS	NULL
II	NULL
truncation	NULL
mutants	NULL
.	NULL

The	NULL
KpnI-Bg	NULL
!	NULL

lI	NULL
fragment	NULL
containing	NULL
HS	NULL
II	NULL
used	NULL
in	NULL
our	NULL
studies	NULL
is	NULL
shown	NULL
at	NULL
top	NULL
.	NULL

The	NULL
first	NULL
nucleotide	NULL
of	NULL
the	NULL
KpnI	NULL
site	NULL
is	NULL
1	NULL
{	NULL
7764	NULL
in	NULL
GenBank	NULL
)	NULL
and	NULL
the	NULL
first	NULL
nucleotide	NULL
of	NULL
the	NULL
Bg/ll	NULL
site	NULL
is	NULL
1455	NULL
.	NULL

Truncation	NULL
mutants	NULL
5	NULL
!	NULL

and	NULL
3	NULL
'	NULL
of	NULL
HS	NULL
II	NULL
are	NULL
depicted	NULL
below	NULL
.	NULL

The	NULL
results	NULL
from	NULL
three	NULL
separate	NULL
experiments	NULL
are	NULL
shown	NULL
at	NULL
right	NULL
.	NULL

Relative	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
comparing	NULL
the	NULL
luciferase	NULL
activity	NULL
of	NULL
a	NULL
given	NULL
mutant	NULL
to	NULL
that	NULL
of	NULL
an	NULL
enhancerless	NULL
reporter	NULL
plasmid	NULL
(	NULL
no	NULL
HS	NULL
II	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
activity	NULL
of	NULL
truncation	NULL
mutants	NULL
in	NULL
each	NULL
experiment	NULL
should	NULL
be	NULL
compared	NULL
to	NULL
wild	NULL
type	NULL
from	NULL
the	NULL
same	NULL
experiment	NULL
.	NULL

Cotransfected	NULL
B19-CAT	NULL
reporter	NULL
construct	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Each	NULL
mutant	NULL
was	NULL
tested	NULL
at	NULL
least	NULL
twice	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
activities	NULL
shown	NULL
are	NULL
representative	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
995	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

Kpn	NULL
Hind	NULL
Bal	NULL
Xba	NULL
Bg	NULL
!	NULL

Relative	NULL
Activity	NULL
1	NULL
LL	NULL
I	NULL
I	NULL
II	NULL
(	NULL
10	NULL
2	NULL
-L	NULL
o	NULL
|	NULL
_	NULL
}	NULL
-	NULL
108	NULL
8.6	NULL
1	NULL
723807	NULL
926.1097	NULL
1455	NULL
807	NULL
|	NULL
t	NULL
5	NULL
i	NULL
Figure	NULL
3	NULL
.	NULL

Localization	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
were	NULL
used	NULL
to	NULL
precisely	NULL
define	NULL
the	NULL
5	NULL
border	NULL
of	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
results	NULL
from	NULL
two	NULL
experiments	NULL
are	NULL
shown	NULL
at	NULL
right	NULL
.	NULL

Relative	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
comparison	NULL
to	NULL
an	NULL
enhancerless	NULL
reporter	NULL
plasmid	NULL
(	NULL
no	NULL
HS	NULL
II	NULL
)	NULL
.	NULL

Cotransfected	NULL
B19-CAT	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
in	NULL
all	NULL
experiments	NULL
.	NULL

Every	NULL
oligonucleotide	NULL
was	NULL
tested	NULL
at	NULL
least	NULL
twice	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
activities	NULL
shown	NULL
are	NULL
representative	NULL
.	NULL

The	NULL
HS	NULL
II	NULL
enhancer	NULL
is	NULL
induced	NULL
with	NULL
erythroid	NULL
maturation	NULL
We	NULL
designed	NULL
experiments	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
has	NULL
a	NULL
role	NULL
in	NULL
the	NULL
increase	NULL
in	NULL
globin	NULL
gene	NULL
expression	NULL
that	NULL
occurs	NULL
with	NULL
hemin-induced	NULL
maturation	NULL
of	NULL
K562	NULL
cells	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
the	NULL
protocol	NULL
of	NULL
Lloyd	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
K562	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
uM	NULL
hemin	NULL
for	NULL
24	NULL
hr	NULL
and	NULL
transfected	NULL
with	NULL
reporter	NULL
plasmids	NULL
with	NULL
or	NULL
without	NULL
an	NULL
HS	NULL
II	NULL
enhancer	NULL
.	NULL

After	NULL
an	NULL
additional	NULL
48	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hemin	NULL
,	NULL
extracts	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
and	NULL
CAT	NULL
activity	NULL
.	NULL

Comparison	NULL
was	NULL
made	NULL
to	NULL
results	NULL
obtained	NULL
with	NULL
standard	NULL
transfections	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
.	NULL

In	NULL
induced	NULL
K562	NULL
cells	NULL
,	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
>	NULL
100-fold	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

This	NULL
contrasted	NULL
to	NULL
the	NULL
10-fold	NULL
increase	NULL
in	NULL
activity	NULL
conferred	NULL
by	NULL
the	NULL
enhancer	NULL
in	NULL
uninduced	NULL
cells	NULL
.	NULL

The	NULL
HS	NULL
II	NULL
enh	NULL
-	NULL
fragment	NULL
was	NULL
inactive	NULL
in	NULL
both	NULL
induced	NULL
and	NULL
uninduced	NULL
cells	NULL
.	NULL

A	NULL
construct	NULL
containing	NULL
only	NULL
46	NULL
bp	NULL
of	NULL
HS	NULL
II	NULL
(	NULL
880-926	NULL
)	NULL
,	NULL
including	NULL
the	NULL
enhancer	NULL
,	NULL
was	NULL
at	NULL
least	NULL
as	NULL
active	NULL
as	NULL
one	NULL
containing	NULL
the	NULL
full	NULL
HS	NULL
II	NULL
fragment	NULL
.	NULL

Both	NULL
constructs	NULL
expressed	NULL
10-	NULL
to	NULL
15-fold	NULL
higher	NULL
in	NULL
induced	NULL
compared	NULL
to	NULL
uninduced	NULL
cells	NULL
.	NULL

By	NULL
primer	NULL
extension	NULL
assay	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
luciferase	NULL
gene	NULL
expression	NULL
in	NULL
induced	NULL
K562	NULL
cells	NULL
,	NULL
conferred	NULL
by	NULL
the	NULL
enhancer	NULL
,	NULL
was	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
luciferase	NULL
transcripts	NULL
correctly	NULL
initiated	NULL
from	NULL
the	NULL
y-globin	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
marked	NULL
increase	NULL
in	NULL
luciferase	NULL
activity	NULL
following	NULL
induction	NULL
,	NULL
correctly	NULL
initiated	NULL
luciferase	NULL
transcripts	NULL
were	NULL
seen	NULL
in	NULL
the	NULL
uninduced	NULL
state	NULL
only	NULL
after	NULL
long	NULL
exposures	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
element	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
the	NULL
increase	NULL
in	NULL
globin	NULL
gene	NULL
expression	NULL
that	NULL
occurs	NULL
during	NULL
erythroid	NULL
maturation	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
enhancer	NULL
activity	NULL
with	NULL
hemin	NULL
induction	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
mobility-shift	NULL
assays	NULL
with	NULL
the	NULL
enhancer	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
[	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
having	NULL
protein	NULL
concentrations	NULL
deter-mined	NULL
,	NULL
uninduced	NULL
and	NULL
induced	NULL
nuclear	NULL
extracts	NULL
were	NULL
standardized	NULL
by	NULL
use	NULL
of	NULL
a	NULL
probe	NULL
to	NULL
the	NULL
widely	NULL
distributed	NULL
transcription	NULL
factor	NULL
Spl	NULL
{	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

This	NULL
probe	NULL
has	NULL
been	NULL
used	NULL
to	NULL
standardize	NULL
chicken	NULL
erythroid	NULL
nuclear	NULL
ex	NULL
996	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
m	NULL
8.6	NULL
8.9	NULL
855	NULL
|	NULL
;	NULL
|	NULL
e	NULL
10.8	NULL
o	NULL
:	NULL
:	NULL
10	NULL
}	NULL
12.4	NULL
880	NULL
}	NULL
1	NULL
926	NULL
13.3	NULL
896	NULL
916	NULL
No	NULL
HSH	NULL
1.0	NULL
1.0	NULL
tracts	NULL
and	NULL
to	NULL
allow	NULL
comparison	NULL
of	NULL
transcription	NULL
factors	NULL
between	NULL
extracts	NULL
(	NULL
Jackson	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

By	NULL
use	NULL
of	NULL
the	NULL
enhancer	NULL
as	NULL
probe	NULL
,	NULL
nuclear	NULL
extract	NULL
from	NULL
induced	NULL
K562	NULL
cells	NULL
generated	NULL
a	NULL
broad	NULL
,	NULL
highly	NULL
retarded	NULL
band	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
bracket	NULL
a	NULL
)	NULL
.	NULL

Extract	NULL
from	NULL
uninduced	NULL
cells	NULL
,	NULL
at	NULL
two-thirds	NULL
the	NULL
concentration	NULL
,	NULL
generated	NULL
a	NULL
cluster	NULL
of	NULL
several	NULL
less	NULL
retarded	NULL
bands	NULL
[	NULL
lane	NULL
4	NULL
,	NULL
bracket	NULL
b	NULL
)	NULL
.	NULL

The	NULL
broad	NULL
,	NULL
highly	NULL
retarded	NULL
band	NULL
seen	NULL
with	NULL
induced	NULL
nuclear	NULL
extract	NULL
could	NULL
be	NULL
reproduced	NULL
by	NULL
increasing	NULL
the	NULL
concentration	NULL
of	NULL
uninduced	NULL
to	NULL
3	NULL
%	NULL
that	NULL
of	NULL
induced	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
4-8	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
several	NULL
less	NULL
retarded	NULL
bands	NULL
were	NULL
generated	NULL
by	NULL
dilution	NULL
of	NULL
induced	NULL
nuclear	NULL
extract	NULL
(	NULL
lanes	NULL
9-13	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggested	NULL
that	NULL
in	NULL
assays	NULL
with	NULL
induced	NULL
nuclear	NULL
extract	NULL
or	NULL
high	NULL
concentrations	NULL
of	NULL
uninduced	NULL
nuclear	NULL
extract	NULL
,	NULL
two	NULL
or	NULL
more	NULL
protein	NULL
molecules	NULL
were	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
.	NULL

These	NULL
data	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
enhancer	NULL
activity	NULL
is	NULL
dependent	NULL
on	NULL
formation	NULL
of	NULL
a	NULL
multimeric	NULL
protein	NULL
complex	NULL
.	NULL

The	NULL
titra-tions	NULL
of	NULL
uninduced	NULL
and	NULL
induced	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
show	NULL
that	NULL
formation	NULL
of	NULL
the	NULL
protein	NULL
complex	NULL
is	NULL
concentration	NULL
dependent	NULL
but	NULL
do	NULL
not	NULL
establish	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
proteins	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
with	NULL
hemin	NULL
induction	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
bands	NULL
observed	NULL
at	NULL
low	NULL
concentrations	NULL
of	NULL
induced	NULL
and	NULL
uninduced	NULL
nuclear	NULL
extracts	NULL
are	NULL
not	NULL
identical	NULL
.	NULL

Induction	NULL
may	NULL
be	NULL
accompanied	NULL
by	NULL
modification	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
phosphorylation	NULL
)	NULL
of	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
or	NULL
the	NULL
appearance	NULL
of	NULL
new	NULL
proteins	NULL
that	NULL
participate	NULL
in	NULL
complex	NULL
formation	NULL
.	NULL

The	NULL
enhancer	NULL
contains	NULL
two	NULL
AP-1-binding	NULL
sites	NULL
,	NULL
both	NULL
of	NULL
which	NULL
are	NULL
required	NULL
for	NULL
full	NULL
activity	NULL
Inspection	NULL
of	NULL
the	NULL
20-bp	NULL
enhancer	NULL
revealed	NULL
tandem	NULL
,	NULL
direct	NULL
9-bp	NULL
repeats	NULL
,	NULL
each	NULL
containing	NULL
a	NULL
full	NULL
match	NULL
to	NULL
the	NULL
7-bp	NULL
activating	NULL
protein-1	NULL
{	NULL
AP-1	NULL
)	NULL
consensus	NULL
binding	NULL
sequence	NULL
,	NULL
TGAGTCA	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

AP-1	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-jun	NULL
gene	NULL
(	NULL
Bohmann	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
,	NULL
but	NULL
now	NULL
the	NULL
designation	NULL
AP-1	NULL
refers	NULL
to	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
of	NULL
proteins	NULL
that	NULL
bind	NULL
as	NULL
dimers	NULL
to	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
Curran	NULL
and	NULL
Franza	NULL
1988	NULL
)	NULL
.	NULL

We	NULL
used	NULL
DNA	NULL
fragments	NULL
containing	NULL
authentic	NULL
AP-1-binding	NULL
sites	NULL
as	NULL
competitors	NULL
in	NULL
gel	NULL
mobility-shift	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
A.	NULL
K562	NULL
Uninduced	NULL
K562	NULL
Induced	NULL
AP-1	NULL
sites	NULL
in	NULL
DCR	NULL
function	NULL
as	NULL
inducible	NULL
enhancer	NULL
B	NULL
.	NULL

-	NULL
Probe	NULL
:	NULL
Wild	NULL
Type	NULL
ENH~	NULL
Cot	NULL
ofc	NULL
Upper	NULL
Lower	NULL
Upper	NULL
Lower	NULL
Hela	NULL
Strand	NULL
Strand	NULL
Strand	NULL
Strand	NULL
Nuclear	NULL
T	NULL
1	NULL
T	NULL
Extract	NULL
(	NULL
ug	NULL
)	NULL
:	NULL
0	NULL
3.2	NULL
6.416	NULL
32	NULL
1	NULL
0	NULL
3.4	NULL
6.8	NULL
17	NULL
34	NULL
'	NULL
K562	NULL
Induced	NULL
04.48.86	NULL
22	NULL
44	NULL
Nuclear	NULL
Extract+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
-	NULL
+	NULL
(	NULL
6.8	NULL
ug	NULL
)	NULL
-	NULL
900	NULL
916	NULL
-	NULL
931	NULL
Figure	NULL
4	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assay	NULL
of	NULL
HS	NULL
IL	NULL
(	NULL
A	NULL
)	NULL
A	NULL
254-bp	NULL
wild-type	NULL
fragment	NULL
[	NULL
723-977	NULL
)	NULL
,	NULL
with	NULL
enhancing	NULL
activity	NULL
equivalent	NULL
to	NULL
the	NULL
1455-bp	NULL
KpnI-Bglll	NULL
fragment	NULL
,	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
.	NULL

Individual	NULL
reactions	NULL
contained	NULL
increasing	NULL
amounts	NULL
(	NULL
left	NULL
to	NULL
right	NULL
)	NULL
of	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
and	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
Left	NULL
]	NULL
Coordinates	NULL
mark	NULL
the	NULL
functionally	NULL
defined	NULL
minimal	NULL
enhancer	NULL
.	NULL

[	NULL
B	NULL
)	NULL
Fragments	NULL
of	NULL
254	NULL
bp	NULL
(	NULL
723-977	NULL
}	NULL
,	NULL
containing	NULL
the	NULL
wild-type	NULL
enhancer	NULL
or	NULL
a	NULL
scrambled	NULL
enhancer	NULL
(	NULL
emk~	NULL
;	NULL
see	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
were	NULL
used	NULL
as	NULL
probe	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assay	NULL
was	NULL
performed	NULL
on	NULL
upper	NULL
and	NULL
lower	NULL
strands	NULL
.	NULL

Individual	NULL
reactions	NULL
contained	NULL
6.8	NULL
pg	NULL
of	NULL
hemin-induced	NULL
K562	NULL
cell	NULL
nuclear	NULL
extract	NULL
(	NULL
+	NULL
)	NULL
or	NULL
no	NULL
nuclear	NULL
extract	NULL
(	NULL
-	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Coordinates	NULL
mark	NULL
the	NULL
minimal	NULL
enhancer	NULL
and	NULL
the	NULL
scrambled	NULL
enhancer	NULL
{	NULL
right	NULL
)	NULL
.	NULL

Sequences	NULL
outside	NULL
the	NULL
scrambled	NULL
enhancer	NULL
(	NULL
723-899	NULL
and	NULL
932-977	NULL
)	NULL
are	NULL
wild	NULL
type	NULL
.	NULL

The	NULL
retarded	NULL
bands	NULL
observed	NULL
in	NULL
extracts	NULL
from	NULL
both	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
with	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
probe	NULL
were	NULL
effectively	NULL
competed	NULL
by	NULL
three	NULL
known	NULL
AP-1-binding	NULL
sites	NULL
(	NULL
Angel	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
competition	NULL
was	NULL
observed	NULL
with	NULL
a	NULL
fragment	NULL
containing	NULL
authentic	NULL
binding	NULL
sites	NULL
for	NULL
NF-E1	NULL
,	NULL
the	NULL
erythroid-specific	NULL
factor	NULL
(	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

To	NULL
study	NULL
binding	NULL
by	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
to	NULL
the	NULL
enhancer	NULL
further	NULL
,	NULL
gel	NULL
mobility-shift	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
erythroid	NULL
and	NULL
nonerythroid	NULL
nuclear	NULL
extracts	NULL
and	NULL
with	NULL
in	NULL
vitro-synthesized	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
ubiquitous	NULL
distribution	NULL
of	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
,	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
was	NULL
bound	NULL
by	NULL
proteins	NULL
present	NULL
in	NULL
all	NULL
nuclear	NULL
extracts	NULL
tested	NULL
{	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
5	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
.	NULL

When	NULL
present	NULL
,	NULL
the	NULL
less	NULL
retarded	NULL
bands	NULL
(	NULL
b	NULL
)	NULL
comigrated	NULL
with	NULL
a	NULL
single	NULL
AP-1	NULL
site	NULL
probe	NULL
{	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
6	NULL
,	NULL
8	NULL
,	NULL
and	NULL
10	NULL
]	NULL
,	NULL
suggesting	NULL
that	NULL
they	NULL
represented	NULL
binding	NULL
to	NULL
one	NULL
AP-1	NULL
site	NULL
and	NULL
that	NULL
the	NULL
highly	NULL
retarded	NULL
band	NULL
(	NULL
a	NULL
)	NULL
represented	NULL
binding	NULL
to	NULL
both	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
enhancer	NULL
.	NULL

The	NULL
latter	NULL
was	NULL
supported	NULL
by	NULL
in	NULL
situ	NULL
phen-	NULL
anthroline/copper	NULL
footprinting	NULL
of	NULL
the	NULL
highly	NULL
retarded	NULL
band	NULL
seen	NULL
with	NULL
induced	NULL
K562	NULL
nuclear	NULL
extract	NULL
.	NULL

A	NULL
footprint	NULL
was	NULL
apparent	NULL
in	NULL
the	NULL
region	NULL
893-918	NULL
,	NULL
encompassing	NULL
both	NULL
AP-1	NULL
sites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
.	NULL

In	NULL
vitro-synthesized	NULL
c-Jun/c-Fos	NULL
heterodimer	NULL
also	NULL
bound	NULL
the	NULL
enhancer	NULL
and	NULL
migrated	NULL
adjacent	NULL
to	NULL
one	NULL
of	NULL
the	NULL
less	NULL
retarded	NULL
bands	NULL
seen	NULL
with	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
and	NULL
slightly	NULL
above	NULL
those	NULL
seen	NULL
with	NULL
uninduced	NULL
K562	NULL
nuclear	NULL
extract	NULL
.	NULL

This	NULL
band	NULL
corresponded	NULL
to	NULL
single	NULL
AP-1	NULL
site	NULL
occupancy	NULL
(	NULL
lanes	NULL
11-16	NULL
)	NULL
.	NULL

By	NULL
increasing	NULL
the	NULL
concentration	NULL
of	NULL
the	NULL
c-Jun/c-Fos	NULL
heterodimer	NULL
,	NULL
a	NULL
band	NULL
can	NULL
be	NULL
elicited	NULL
that	NULL
comigrates	NULL
with	NULL
the	NULL
highly	NULL
retarded	NULL
band	NULL
seen	NULL
with	NULL
nuclear	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

c-Jun	NULL
or	NULL
c-Fos	NULL
alone	NULL
shows	NULL
little	NULL
or	NULL
no	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
,	NULL
respectively	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
clearly	NULL
that	NULL
members	NULL
of	NULL
the	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
are	NULL
able	NULL
to	NULL
bind	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
.	NULL

We	NULL
interpret	NULL
these	NULL
data	NULL
to	NULL
suggest	NULL
that	NULL
the	NULL
co-migrating	NULL
band	NULL
formed	NULL
in	NULL
extracts	NULL
of	NULL
HeLa	NULL
cells	NULL
is	NULL
a	NULL
c-Jun/c-Fos	NULL
heterodimer	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
this	NULL
band	NULL
in	NULL
extracts	NULL
of	NULL
uninduced	NULL
K562	NULL
cells	NULL
suggests	NULL
that	NULL
the	NULL
complex	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
997	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

Figure	NULL
5	NULL
.	NULL

Mutation	NULL
of	NULL
enhancer	NULL
sequence	NULL
within	NULL
HS	NULL
II	NULL
eliminates	NULL
all	NULL
activity	NULL
.	NULL

Thirty-one	NULL
bp	NULL
KpnI	NULL
HindIII	NULL
Ball	NULL
Xbal	NULL
BgllI	NULL
L	NULL
__	NULL
[	NULL
1	NULL
j	NULL
[	NULL
-1	NULL
1097	NULL
1455	NULL
minimal	NULL
enhancer	NULL
940	NULL
(	NULL
200-931	NULL
)	NULL
of	NULL
the	NULL
full	NULL
HS	NULL
II	NULL
fragment	NULL
(	NULL
1455	NULL
bp	NULL
)	NULL
was	NULL
scrambled	NULL
,	NULL
including	NULL
16	NULL
of	NULL
the	NULL
20	NULL
bp	NULL
of	NULL
the	NULL
min-	NULL
881	NULL
imal	NULL
enhancer	NULL
.	NULL

This	NULL
construct	NULL
was	NULL
designated	NULL
HS	NULL
II	NULL
enh	NULL
~	NULL
.	NULL

The	NULL
location	NULL
of	NULL
the	NULL
scrambled	NULL
sequence	NULL
within	NULL
HS	NULL
II	NULL
enh~	NULL
is	NULL
expanded	NULL
.	NULL

The	NULL
enhancing	NULL
activity	NULL
of	NULL
this	NULL
construct	NULL
was	NULL
compared	NULL
to	NULL
wild-type	NULL
HS	NULL
II	NULL
and	NULL
to	NULL
an	NULL
enhancerless	NULL
reporter	NULL
plasmid	NULL
(	NULL
no	NULL
HS	NULL
II	NULL
)	NULL
,	NULL
as	NULL
shown	NULL
at	NULL
bottom	NULL
.	NULL

Cotransfected	NULL
B19-CAT	NULL
served	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

On	NULL
repetition	NULL
,	NULL
this	NULL
experiment	NULL
gave	NULL
virtually	NULL
identical	NULL
results	NULL
.	NULL

binding	NULL
the	NULL
enhancer	NULL
in	NULL
uninduced	NULL
K562	NULL
cells	NULL
is	NULL
not	NULL
the	NULL
same	NULL
as	NULL
that	NULL
in	NULL
HeLa	NULL
cells	NULL
but	NULL
represents	NULL
either	NULL
a	NULL
modification	NULL
or	NULL
a	NULL
different	NULL
dimer	NULL
from	NULL
the	NULL
Jun/Fos	NULL
dimer	NULL
fami-lies	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
individual	NULL
AP-1-binding	NULL
sites	NULL
to	NULL
enhancer	NULL
function	NULL
and	NULL
protein	NULL
complex	NULL
formation	NULL
,	NULL
the	NULL
enhancer	NULL
was	NULL
scanned	NULL
with	NULL
mutants	NULL
in	NULL
3-bp	NULL
intervals	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
.	NULL

These	NULL
triplet	NULL
scanning	NULL
mutants	NULL
were	NULL
assayed	NULL
for	NULL
activity	NULL
in	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
{	NULL
mutants	NULL
1-6	NULL
}	NULL
caused	NULL
a	NULL
loss	NULL
in	NULL
activity	NULL
to	NULL
20-58	NULL
%	NULL
of	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
wild-type	NULL
enhancer	NULL
in	NULL
the	NULL
uninduced	NULL
state	NULL
and	NULL
6-34	NULL
%	NULL
of	NULL
that	NULL
seen	NULL
in	NULL
the	NULL
induced	NULL
state	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

Mutant	NULL
7	NULL
,	NULL
which	NULL
falls	NULL
outside	NULL
both	NULL
AP-1	NULL
consensus	NULL
sequences	NULL
,	NULL
was	NULL
as	NULL
active	NULL
as	NULL
the	NULL
wild-type	NULL
enhancer	NULL
in	NULL
the	NULL
uninduced	NULL
state	NULL
and	NULL
slightly	NULL
less	NULL
active	NULL
in	NULL
the	NULL
induced	NULL
state	NULL
.	NULL

Those	NULL
mutants	NULL
with	NULL
the	NULL
lowest	NULL
activity	NULL
also	NULL
tended	NULL
to	NULL
have	NULL
the	NULL
lowest	NULL
inducibility	NULL
,	NULL
although	NULL
inducibility	NULL
per	NULL
se	NULL
was	NULL
preserved	NULL
with	NULL
even	NULL
the	NULL
least	NULL
active	NULL
mutants	NULL
.	NULL

However	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
least	NULL
active	NULL
mutants	NULL
of	NULL
either	NULL
AP-1	NULL
site	NULL
{	NULL
mutants	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
was	NULL
far	NULL
below	NULL
that	NULL
of	NULL
the	NULL
wild-type	NULL
enhancer	NULL
in	NULL
the	NULL
induced	NULL
state	NULL
.	NULL

These	NULL
data	NULL
lend	NULL
support	NULL
to	NULL
our	NULL
hypothesis	NULL
that	NULL
complex	NULL
formation	NULL
involving	NULL
both	NULL
AP-1	NULL
sites	NULL
is	NULL
necessary	NULL
for	NULL
full	NULL
enhancer	NULL
activity	NULL
.	NULL

The	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
enhancer	NULL
mutants	NULL
cor-	NULL
Table	NULL
1	NULL
.	NULL

The	NULL
HS	NULL
II	NULL
enhancer	NULL
is	NULL
inducible	NULL
,	NULL
o-	NULL
Nie	NULL
--	NULL
CTCAAGCACAGCAATGCTGAGTCATGATGAGTCATGCTGAGGCTTAGGGTGTGTGCCCAG	NULL
IGGGGGGATCCGGGCCCGCATGCGTCGAGGTAI	NULL
scrambled	NULL
sequence	NULL
Relative	NULL
Activity	NULL
HSI	NULL
(	NULL
1.5	NULL
kb	NULL
)	NULL
8.6	NULL
HSIL	NULL
ENH~	NULL
0.4	NULL
No	NULL
HSH	NULL
1.0	NULL
related	NULL
quite	NULL
well	NULL
with	NULL
their	NULL
ability	NULL
to	NULL
form	NULL
the	NULL
highly	NULL
retarded	NULL
multimeric	NULL
complex	NULL
in	NULL
a	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
with	NULL
induced	NULL
K562	NULL
nuclear	NULL
extract	NULL
[	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

With	NULL
mutants	NULL
of	NULL
either	NULL
AP-1	NULL
site	NULL
(	NULL
mutants	NULL
1-6	NULL
)	NULL
,	NULL
the	NULL
band	NULL
corresponding	NULL
to	NULL
single-site	NULL
occupancy	NULL
(	NULL
b	NULL
)	NULL
predominated	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
wild-type	NULL
enhancer	NULL
and	NULL
mutant	NULL
7	NULL
,	NULL
which	NULL
leave	NULL
both	NULL
AP-1	NULL
consensus	NULL
sequences	NULL
intact	NULL
,	NULL
generated	NULL
the	NULL
band	NULL
corresponding	NULL
to	NULL
occupancy	NULL
of	NULL
both	NULL
AP-1	NULL
sites	NULL
{	NULL
a	NULL
)	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assay	NULL
of	NULL
the	NULL
enhancer	NULL
mutants	NULL
with	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
gave	NULL
a	NULL
very	NULL
similar	NULL
pat-tern	NULL
,	NULL
but	NULL
the	NULL
bands	NULL
corresponding	NULL
to	NULL
single-site	NULL
occupancy	NULL
(	NULL
b	NULL
)	NULL
are	NULL
closer	NULL
together	NULL
than	NULL
with	NULL
induced	NULL
K562	NULL
nuclear	NULL
extract	NULL
.	NULL

These	NULL
results	NULL
establish	NULL
that	NULL
formation	NULL
of	NULL
the	NULL
multimeric	NULL
complex	NULL
(	NULL
and	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
en-hancer	NULL
)	NULL
requires	NULL
both	NULL
AP-1	NULL
sites	NULL
.	NULL

Discussion	NULL
The	NULL
enhancer	NULL
within	NULL
HS	NULL
II	NULL
has	NULL
been	NULL
localized	NULL
to	NULL
two	NULL
tandemly	NULL
repeated	NULL
AP-1	NULL
consensus	NULL
binding	NULL
sites	NULL
within	NULL
an	NULL
18-bp	NULL
segment	NULL
.	NULL

These	NULL
binding	NULL
sites	NULL
are	NULL
phased	NULL
10	NULL
bp	NULL
apart	NULL
,	NULL
placing	NULL
them	NULL
on	NULL
successive	NULL
helical	NULL
turns	NULL
of	NULL
the	NULL
DNA	NULL
molecule	NULL
.	NULL

An	NULL
unexpected	NULL
finding	NULL
was	NULL
the	NULL
increase	NULL
in	NULL
enhancer	NULL
activity	NULL
as	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
matured	NULL
in	NULL
response	NULL
to	NULL
chemical	NULL
induction	NULL
.	NULL

These	NULL
observations	NULL
led	NULL
us	NULL
to	NULL
propose	NULL
a	NULL
physiological	NULL
role	NULL
for	NULL
the	NULL
enhancer	NULL
in	NULL
contributing	NULL
to	NULL
the	NULL
increase	NULL
in	NULL
globin	NULL
gene	NULL
Uninduced	NULL
Hemin	NULL
induced	NULL
luciferase	NULL
CAT	NULL
luciferase	NULL
CAT	NULL
activity	NULL
activity	NULL
activity	NULL
activity	NULL
(	NULL
per	NULL
1000	NULL
{	NULL
per	NULL
1000	NULL
luciferase/	NULL
relative	NULL
{	NULL
per	NULL
1000	NULL
{	NULL
per	NULL
1000	NULL
luciferase/	NULL
relative	NULL
light	NULL
units	NULL
)	NULL
cpm	NULL
)	NULL
CAT®	NULL
activity	NULL
light	NULL
units	NULL
)	NULL
cpm	NULL
]	NULL
CAT®	NULL
activity	NULL
No	NULL
HS	NULL
II	NULL
2.9	NULL
10.5	NULL
0.4	NULL
1.0	NULL
3.3	NULL
22.8	NULL
0.2	NULL
0.4	NULL
HS	NULL
II	NULL
{	NULL
1455	NULL
bp	NULL
)	NULL
38.4	NULL
12.5	NULL
4.0	NULL
10.8	NULL
746°	NULL
20.5	NULL
42.7	NULL
115	NULL
HS	NULL
II	NULL
(	NULL
46	NULL
bp	NULL
)	NULL
73.0	NULL
21.0	NULL
4.0	NULL
10.9	NULL
1,527°	NULL
27.1	NULL
63.4	NULL
171	NULL
HS	NULL
I	NULL
enh	NULL
-	NULL
1.1	NULL
10.7	NULL
0.1	NULL
0.4	NULL
4.0	NULL
47.4	NULL
0.1	NULL
0.2	NULL
No	NULL
extract	NULL
0.1	NULL
3.0	NULL
-	NULL
-	NULL
0.1	NULL
3.0	NULL
-	NULL
«	NULL
Luciferase/CAT	NULL
activity	NULL
ratio	NULL
,	NULL
after	NULL
subtracting	NULL
background	NULL
(	NULL
no	NULL
extract	NULL
]	NULL
from	NULL
each	NULL
.	NULL

PSamples	NULL
giving	NULL
values	NULL
>	NULL
100,000	NULL
light	NULL
units	NULL
were	NULL
diluted	NULL
,	NULL
reassayed	NULL
,	NULL
and	NULL
corrected	NULL
for	NULL
dilution	NULL
by	NULL
the	NULL
appropriate	NULL
factor	NULL
.	NULL

These	NULL
represent	NULL
corrected	NULL
values	NULL
.	NULL

998	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
A.	NULL
Hemin	NULL
nid	NULL
#	NULL
«	NULL
se	NULL
238-	NULL
#	NULL
M	NULL
_	NULL
am-	NULL
y	NULL
Luciferase	NULL
217-	NULL
#	NULL
fl	NULL
B	NULL
a	NULL
B	NULL
Hemin	NULL
Mm	NULL
-	NULL
+	NULL
7a	NULL
-	NULL
“	NULL
ﬂy—yelobin	NULL
Figure	NULL
6	NULL
.	NULL

-	NULL
Primer	NULL
extension	NULL
analysis	NULL
of	NULL
chimeric	NULL
y-globin/luci-ferase	NULL
transcripts	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
HS	NULL
II	NULL
enhancer	NULL
[	NULL
46	NULL
bp	NULL
)	NULL
containing	NULL
reporter	NULL
plasmid	NULL
and	NULL
induced	NULL
with	NULL
20	NULL
um	NULL
hemin	NULL
(	NULL
+	NULL
]	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
-	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Molecular	NULL
weight	NULL
marker	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
leftmost	NULL
lane	NULL
,	NULL
with	NULL
the	NULL
238-and	NULL
217-bp	NULL
bands	NULL
indicated	NULL
.	NULL

Correctly	NULL
initiated	NULL
y-globin/luci-ferase	NULL
mRNA	NULL
gives	NULL
a	NULL
228-bp	NULL
extension	NULL
product	NULL
.	NULL

Minor	NULL
bands	NULL
present	NULL
in	NULL
the	NULL
uninduced	NULL
and	NULL
induced	NULL
lanes	NULL
were	NULL
also	NULL
seen	NULL
with	NULL
RNA	NULL
from	NULL
untransfected	NULL
K562	NULL
cells	NULL
and	NULL
represent	NULL
artifacts	NULL
from	NULL
the	NULL
primer	NULL
extension	NULL
assay	NULL
.	NULL

{	NULL
B	NULL
)	NULL
Molecular	NULL
weight	NULL
marker	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
leftmost	NULL
lane	NULL
,	NULL
with	NULL
the	NULL
76-bp	NULL
band	NULL
indicated	NULL
.	NULL

Correctly	NULL
initiated	NULL
endogenous	NULL
y-globin	NULL
mRNA	NULL
gives	NULL
a	NULL
76-bp	NULL
extension	NULL
product	NULL
.	NULL

expression	NULL
that	NULL
is	NULL
characteristic	NULL
of	NULL
erythroid	NULL
cell	NULL
maturation	NULL
.	NULL

This	NULL
enhancer	NULL
seems	NULL
likely	NULL
to	NULL
be	NULL
one	NULL
of	NULL
several	NULL
regulatory	NULL
elements	NULL
,	NULL
marked	NULL
by	NULL
the	NULL
four	NULL
5	NULL
HS	NULL
sites	NULL
,	NULL
that	NULL
are	NULL
required	NULL
for	NULL
tissue-specific	NULL
,	NULL
high-level	NULL
expression	NULL
of	NULL
the	NULL
individual	NULL
globin	NULL
genes	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

The	NULL
enhancer	NULL
was	NULL
mapped	NULL
by	NULL
utilizing	NULL
short-term	NULL
{	NULL
transient	NULL
)	NULL
assays	NULL
of	NULL
unintegrated	NULL
reporter	NULL
genes	NULL
,	NULL
but	NULL
it	NULL
is	NULL
also	NULL
active	NULL
when	NULL
stably	NULL
integrated	NULL
.	NULL

The	NULL
role	NULL
of	NULL
the	NULL
enhancer	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
globin	NULL
genes	NULL
was	NULL
first	NULL
suspected	NULL
in	NULL
our	NULL
laboratory	NULL
when	NULL
we	NULL
observed	NULL
that	NULL
the	NULL
1455-bp	NULL
HS	NULL
II	NULL
fragment	NULL
was	NULL
required	NULL
for	NULL
induced	NULL
expression	NULL
of	NULL
a	NULL
stably	NULL
integrated	NULL
Ay-globin	NULL
gene	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
as	NULL
reflected	NULL
by	NULL
the	NULL
concentration	NULL
of	NULL
correctly	NULL
initiated	NULL
mRNA	NULL
[	NULL
Sorrentino	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
.	NULL

The	NULL
46-bp	NULL
enhancer	NULL
was	NULL
shown	NULL
to	NULL
confer	NULL
inducibility	NULL
,	NULL
whereas	NULL
an	NULL
integrated	NULL
+y-globin	NULL
gene	NULL
linked	NULL
to	NULL
the	NULL
HS	NULL
II	NULL
enh	NULL
~-	NULL
fragment	NULL
was	NULL
unin-ducible	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
enhancer	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
full	NULL
DCR/LAR	NULL
activity	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

A	NULL
construct	NULL
of	NULL
fragments	NULL
,	NULL
containing	NULL
sites	NULL
IV	NULL
,	NULL
HII	NULL
,	NULL
and	NULL
II	NULL
,	NULL
allowed	NULL
a	NULL
linked	NULL
Ay-globin	NULL
gene	NULL
to	NULL
be	NULL
expressed	NULL
at	NULL
the	NULL
same	NULL
level	NULL
as	NULL
an	NULL
endogenous	NULL
*y-globin	NULL
gene	NULL
in	NULL
K562	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
Ay-globin	NULL
gene	NULL
in	NULL
a	NULL
construct	NULL
with	NULL
HS	NULL
AP-1	NULL
sites	NULL
in	NULL
DCR	NULL
function	NULL
as	NULL
inducible	NULL
enhancer	NULL
IV	NULL
,	NULL
HS	NULL
III	NULL
,	NULL
and	NULL
HS	NULL
II	NULL
enh~	NULL
was	NULL
expressed	NULL
at	NULL
a	NULL
significantly	NULL
lower	NULL
level	NULL
(	NULL
Sorrentino	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
in	NULL
K562	NULL
cells	NULL
have	NULL
been	NULL
obtained	NULL
by	NULL
study	NULL
of	NULL
the	NULL
y-globin	NULL
gene	NULL
or	NULL
its	NULL
promoter	NULL
.	NULL

Others	NULL
have	NULL
reported	NULL
modest	NULL
induction	NULL
of	NULL
the	NULL
y-globin	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
but	NULL
in	NULL
<	NULL
50	NULL
%	NULL
of	NULL
stably	NULL
transfected	NULL
K562	NULL
clones	NULL
(	NULL
Kioussis	NULL
et	NULL
al	NULL
.	NULL

1985	NULL
;	NULL
Donovan-Peluso	NULL
1987	NULL
)	NULL
.	NULL

A	NULL
hybrid	NULL
y/B	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
B-globin	NULL
gene	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
modestly	NULL
inducible	NULL
in	NULL
K562	NULL
cells	NULL
without	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
(	NULL
Lin	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
gene	NULL
linked	NULL
to	NULL
a	NULL
nonglobin	NULL
promoter	NULL
,	NULL
or	NULL
the	NULL
promoter	NULL
linked	NULL
to	NULL
a	NULL
nonglobin	NULL
gene	NULL
stably	NULL
integrated	NULL
into	NULL
MEL	NULL
cells	NULL
,	NULL
is	NULL
variably	NULL
expressed	NULL
but	NULL
most	NULL
often	NULL
highly	NULL
inducible	NULL
without	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
(	NULL
Chao	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
;	NULL
Wright	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
,	NULL
1984	NULL
)	NULL
.	NULL

Inducibility	NULL
of	NULL
the	NULL
B-globin	NULL
promoter	NULL
depends	NULL
on	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
recognition	NULL
site	NULL
for	NULL
a	NULL
CCAAT-binding	NULL
protein	NULL
[	NULL
(	NULL
CP1	NULL
)	NULL
and	NULL
one	NULL
of	NULL
two	NULL
NF-El	NULL
sites	NULL
in	NULL
the	NULL
B-globin	NULL
promoter	NULL
{	NULL
de	NULL
Boer	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
.	NULL

The	NULL
basis	NULL
for	NULL
this	NULL
difference	NULL
in	NULL
the	NULL
requirement	NULL
for	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
for	NULL
globin	NULL
gene	NULL
inducibility	NULL
between	NULL
mouse	NULL
and	NULL
human	NULL
erythroleukemia	NULL
cells	NULL
is	NULL
uncertain	NULL
at	NULL
present	NULL
.	NULL

Perhaps	NULL
there	NULL
is	NULL
redundancy	NULL
in	NULL
regulatory	NULL
mechanisms	NULL
,	NULL
as	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
other	NULL
systems	NULL
.	NULL

Experiments	NULL
are	NULL
in	NULL
progress	NULL
to	NULL
define	NULL
the	NULL
function	NULL
of	NULL
the	NULL
enhancer	NULL
and	NULL
its	NULL
effect	NULL
on	NULL
human	NULL
globin	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

The	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
of	NULL
proteins	NULL
,	NULL
collectively	NULL
referred	NULL
to	NULL
as	NULL
AP-1	NULL
(	NULL
Curran	NULL
and	NULL
Franza	NULL
1988	NULL
)	NULL
,	NULL
share	NULL
a	NULL
highly	NULL
homologous	NULL
domain	NULL
composed	NULL
of	NULL
a	NULL
basic	NULL
segment	NULL
and	NULL
a	NULL
leucine	NULL
zipper	NULL
(	NULL
Gentz	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
;	NULL
Kouzarides	NULL
and	NULL
Ziff	NULL
1989	NULL
;	NULL
Ransone	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
;	NULL
Turner	NULL
and	NULL
Tjian	NULL
1989	NULL
)	NULL
.	NULL

Members	NULL
of	NULL
the	NULL
jun	NULL
family	NULL
bind	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
DNA	NULL
as	NULL
a	NULL
heterodimeric	NULL
complex	NULL
with	NULL
members	NULL
of	NULL
the	NULL
fos	NULL
family	NULL
(	NULL
Halazonetis	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
;	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
}	NULL
.	NULL

The	NULL
dimer	NULL
binds	NULL
to	NULL
a	NULL
single	NULL
AP-1	NULL
site	NULL
.	NULL

We	NULL
therefore	NULL
infer	NULL
that	NULL
the	NULL
tandem	NULL
sites	NULL
that	NULL
make	NULL
up	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
bind	NULL
two	NULL
dimers	NULL
forming	NULL
a	NULL
multimeric	NULL
complex	NULL
of	NULL
at	NULL
least	NULL
four	NULL
polypeptide	NULL
chains	NULL
.	NULL

The	NULL
jun	NULL
and	NULL
fos	NULL
families	NULL
are	NULL
expressed	NULL
ubiquitously	NULL
,	NULL
although	NULL
individual	NULL
genes	NULL
may	NULL
be	NULL
differentially	NULL
expressed	NULL
in	NULL
specific	NULL
cell	NULL
types	NULL
.	NULL

This	NULL
has	NULL
been	NULL
shown	NULL
for	NULL
the	NULL
fun	NULL
genes	NULL
in	NULL
the	NULL
tissues	NULL
of	NULL
adult	NULL
mice	NULL
(	NULL
Hirai	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
enhancer	NULL
was	NULL
bound	NULL
by	NULL
proteins	NULL
expressed	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
tested	NULL
,	NULL
but	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
enhancer	NULL
need	NULL
not	NULL
be	NULL
the	NULL
same	NULL
in	NULL
extracts	NULL
from	NULL
different	NULL
cell	NULL
types	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
on	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
,	NULL
we	NULL
found	NULL
differences	NULL
in	NULL
mobility	NULL
between	NULL
uninduced	NULL
K562	NULL
and	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
relative	NULL
to	NULL
in	NULL
vitro-synthesized	NULL
c-Jun/c-Fos	NULL
heterodimer	NULL
.	NULL

We	NULL
also	NULL
found	NULL
differences	NULL
between	NULL
induced	NULL
K562	NULL
and	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
when	NULL
single-site	NULL
occupancy	NULL
bands	NULL
were	NULL
generated	NULL
by	NULL
enhancer	NULL
mutants	NULL
with	NULL
one	NULL
AP-1	NULL
site	NULL
ablated	NULL
.	NULL

Tuan	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
is	NULL
erythroid	NULL
specific	NULL
.	NULL

In	NULL
our	NULL
experiments	NULL
,	NULL
the	NULL
enhancer	NULL
gave	NULL
only	NULL
a	NULL
threefold	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
expression	NULL
in	NULL
Hela	NULL
cells	NULL
but	NULL
more	NULL
than	NULL
a	NULL
100-fold	NULL
increase	NULL
in	NULL
induced	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
promoter	NULL
in	NULL
our	NULL
experiments	NULL
may	NULL
have	NULL
contributed	NULL
to	NULL
this	NULL
tissue	NULL
specificity	NULL
,	NULL
although	NULL
Tuan	NULL
et	NULL
al	NULL
.	NULL

{	NULL
1989	NULL
)	NULL
reported	NULL
tissue	NULL
specificity	NULL
of	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
999	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

(	NULL
'pus3a	NULL
;	NULL
10f	NULL
a8od	NULL
Surov	NULL
{	NULL
22g	NULL
)	NULL
+	NULL
,	NULL
anil	NULL
OL	NULL
6	NULL
zt	NULL
it	NULL
Of	NULL
6L	NULL
gL	NULL
Ll	NULL
91	NULL
SL	NULL
p	NULL
}	NULL
BL	NULL
CL	NULL
LL	NULL
i	NULL
’	NULL
;	NULL
a	NULL
L-dV	NULL
IISH	NULL
L-dV	NULL
IISH	NULL
I~dV	NULL
IISH	NULL
I-d¥	NULL
IISH	NULL
IISH	NULL
ISH	NULL
IISH	NULL
_	NULL
IISH	NULL
L	NULL
I	NULL
I	NULL
L	NULL
Mh	NULL
1	NULL
YN	NULL
un	NULL
[	NULL
-a	NULL
_	NULL
sopa	NULL
-	NULL
sop-9	NULL
IZ9SMNZISM	NULL
2I	NULL
@	NULL
H	NULL
Sop-9	NULL
+	NULL
un|-9	NULL
+	NULL
unf-9	NULL
€L	NULL
CL	NULL
LL	NULL
OL	NULL
6	NULL
8	NULL
F4	NULL
w	NULL
»	NULL
an	NULL
om	NULL
~	NULL
gn	NULL
paanpul	NULL
2999	NULL
9	NULL
8	NULL
r	NULL
¢	NULL
&	NULL
)	NULL
|	NULL
sus	NULL
,	NULL
®	NULL
8	NULL
£	NULL
.	NULL

9	NULL
.S	NULL
sod	NULL
aur7	NULL
:	NULL
ulq101q	NULL
10	NULL
jpeg	NULL
egon	NULL
``	NULL
£9	NULL
shh	NULL
a	NULL
tilt	NULL
upa	NULL
l	NULL
L-dV	NULL
IISH	NULL
i-d¥	NULL
IISH	NULL
1~dV	NULL
IISH	NULL
I-d¥	NULL
IISH	NULL
I-d¥	NULL
IISH	NULL
:	NULL
agoid	NULL
L	NULL
I	NULL
L	NULL
I	NULL
L	NULL
I	NULL
``	NULL
p	NULL
J	NULL
e1	NULL
@	NULL
H	NULL
TI3W	NULL
-	NULL
12995X	NULL
-	NULL
Ne99M	NULL
6	NULL
g	NULL
%	NULL
9	NULL
9	NULL
fP	NULL
f	NULL
SL	NULL
LL	NULL
XA	NULL
-	NULL
X¥	NULL
%	NULL
e	NULL
98	NULL
9°	NULL
OL	NULL
X	NULL
%	NULL
8°L	NULL
b	NULL
sine	NULL
X	NULL
%	NULL
XMAE	NULL
Xe	NULL
XHAL	NULL
*	NULL
%	NULL
XL	NULL
6°0	NULL
gilt	NULL
for	NULL
gol	NULL
Fo	NULL
Cf	NULL
Fr	NULL
L	NULL
paonpu	NULL
]	NULL
2999	NULL
paonpulun	NULL
29SXM	NULL
1299X	NULL
L4	NULL
6	NULL
f	NULL
xp	NULL
|	NULL
3t	NULL
co	NULL
vr	NULL
gue	NULL
]	NULL
:	NULL
uonejua9u03	NULL
ds	NULL
annejay	NULL
:	NULL
(	NULL
bri	NULL
)	NULL
jpe11xq3	NULL
aeajnN	NULL
ne9SyX	NULL
L	NULL
Lu	NULL
o	NULL
O	NULL
s	NULL
&	NULL
»	NULL
Xf	NULL
mp4	NULL
9	NULL
is	NULL
C	NULL
.	NULL

#	NULL
A	NULL
~	NULL
®	NULL
3	NULL
PP	NULL
~	NULL
L	NULL
L	NULL
paonpulup	NULL
29994	NULL
=	NULL
ag9ueyug	NULL
|ISH	NULL
Jdg	NULL
:	NULL
agoid	NULL
``	NULL
V	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1000	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
the	NULL
enhancer	NULL
with	NULL
a	NULL
nonglobin	NULL
promoter	NULL
.	NULL

In	NULL
transgenic	NULL
mice	NULL
,	NULL
an	NULL
882-bp	NULL
fragment	NULL
of	NULL
HS	NULL
II	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
enhancer	NULL
,	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
sufficient	NULL
for	NULL
high-level	NULL
,	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
{	NULL
Curtin	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

How	NULL
can	NULL
the	NULL
apparent	NULL
erythroid	NULL
specificity	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
be	NULL
equated	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
tandem	NULL
AP-1-binding	NULL
sites	NULL
?	NULL

As	NULL
noted	NULL
above	NULL
,	NULL
the	NULL
polypeptides	NULL
present	NULL
in	NULL
the	NULL
complex	NULL
formed	NULL
on	NULL
these	NULL
sites	NULL
may	NULL
differ	NULL
in	NULL
various	NULL
cells	NULL
,	NULL
Recent	NULL
data	NULL
suggest	NULL
that	NULL
there	NULL
is	NULL
an	NULL
erythroid-specific	NULL
DNA-binding	NULL
protein	NULL
,	NULL
designated	NULL
NF-E2	NULL
,	NULL
that	NULL
binds	NULL
to	NULL
a	NULL
sequence	NULL
,	NULL
GCTGAGTCA	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
(	NULL
Mignotte	NULL
et	NULL
al	NULL
.	NULL

1989a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

An	NULL
NF-E2Z-binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
inducibility	NULL
of	NULL
the	NULL
porphobilinogen	NULL
gene	NULL
erythroid	NULL
promoter	NULL
in	NULL
MEL	NULL
cells	NULL
.	NULL

The	NULL
sequence	NULL
identified	NULL
as	NULL
being	NULL
required	NULL
for	NULL
NF-E2	NULL
binding	NULL
is	NULL
present	NULL
in	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
.	NULL

The	NULL
potential	NULL
role	NULL
for	NULL
NF-E2	NULL
in	NULL
the	NULL
apparent	NULL
erythroid	NULL
specificity	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
can	NULL
only	NULL
be	NULL
a	NULL
matter	NULL
of	NULL
speculation	NULL
at	NULL
present	NULL
.	NULL

The	NULL
c-jun	NULL
and	NULL
c-fos	NULL
genes	NULL
are	NULL
among	NULL
a	NULL
class	NULL
,	NULL
designated	NULL
as	NULL
early	NULL
response	NULL
genes	NULL
,	NULL
that	NULL
is	NULL
part	NULL
of	NULL
the	NULL
immediate	NULL
response	NULL
of	NULL
various	NULL
cells	NULL
to	NULL
hormone	NULL
or	NULL
serum	NULL
stimulation	NULL
.	NULL

These	NULL
genes	NULL
appear	NULL
to	NULL
be	NULL
components	NULL
of	NULL
a	NULL
general	NULL
signaling	NULL
system	NULL
used	NULL
to	NULL
regulate	NULL
specific	NULL
genes	NULL
in	NULL
various	NULL
cell	NULL
types	NULL
(	NULL
Curran	NULL
and	NULL
Franza	NULL
1988	NULL
)	NULL
.	NULL

The	NULL
c-fos	NULL
gene	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
late-stage	NULL
erythro-blasts	NULL
(	NULL
Caubet	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

The	NULL
c-fos	NULL
,	NULL
c-jun	NULL
,	NULL
and	NULL
jun-B	NULL
genes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
K562	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
(	NULL
Pertovaara	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

We	NULL
have	NULL
preliminary	NULL
data	NULL
that	NULL
hemin	NULL
stimulation	NULL
results	NULL
in	NULL
increases	NULL
in	NULL
c-jun	NULL
and	NULL
c-fos	NULL
mRNA	NULL
levels	NULL
in	NULL
K562	NULL
cells	NULL
(	NULL
R.	NULL
Redner	NULL
,	NULL
pers	NULL
.	NULL

comm	NULL
.	NULL
)	NULL

.	NULL

Also	NULL
of	NULL
interest	NULL
will	NULL
be	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
physiological	NULL
regulator	NULL
erythro-poietin	NULL
on	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
in	NULL
normal	NULL
erythroid	NULL
cells	NULL
.	NULL

There	NULL
is	NULL
precedence	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
AP-1-binding	NULL
sites	NULL
in	NULL
enhancer	NULL
function	NULL
.	NULL

c-Jun	NULL
and	NULL
c-Fos	NULL
,	NULL
as	NULL
part	NULL
of	NULL
the	NULL
early	NULL
response	NULL
to	NULL
various	NULL
stimuli	NULL
,	NULL
allow	NULL
AP-1-binding	NULL
sites	NULL
to	NULL
confer	NULL
inducibility	NULL
on	NULL
promoter	NULL
function	NULL
(	NULL
Angel	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
;	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
]	NULL
.	NULL

Functionally	NULL
important	NULL
AP-l-binding	NULL
sites	NULL
have	NULL
been	NULL
found	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
the	NULL
chicken	NULL
B-globin	NULL
(	NULL
Reitman	NULL
and	NULL
Felsenfeld	NULL
1988	NULL
)	NULL
,	NULL
metallothionein	NULL
II	NULL
(	NULL
Lee	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
,	NULL
and	NULL
collagenase	NULL
genes	NULL
(	NULL
Angel	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
,	NULL
and	NULL
the	NULL
enhancer	NULL
of	NULL
a	NULL
strain	NULL
of	NULL
polyomavirus	NULL
(	NULL
Dynan	NULL
1989	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
chicken	NULL
B-globin	NULL
enhancer	NULL
AP-1	NULL
-binding	NULL
site	NULL
reduces	NULL
enhancer	NULL
activity	NULL
to	NULL
10	NULL
%	NULL
of	NULL
wild	NULL
type	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
this	NULL
enhancer	NULL
,	NULL
like	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
,	NULL
appears	NULL
to	NULL
be	NULL
rela-	NULL
AP-1	NULL
sites	NULL
in	NULL
DCR	NULL
function	NULL
as	NULL
inducible	NULL
enhancer	NULL
tively	NULL
simple	NULL
.	NULL

Two	NULL
footprinted	NULL
regions	NULL
,	NULL
one	NULL
including	NULL
the	NULL
AP-1	NULL
site	NULL
and	NULL
the	NULL
other	NULL
consisting	NULL
of	NULL
two	NULL
Eryf-1	NULL
sites	NULL
{	NULL
the	NULL
chicken	NULL
equivalent	NULL
of	NULL
NF-E1	NULL
}	NULL
,	NULL
are	NULL
sufficient	NULL
for	NULL
positive	NULL
regulation	NULL
by	NULL
the	NULL
chicken	NULL
B-globin	NULL
enhancer	NULL
.	NULL

The	NULL
role	NULL
of	NULL
this	NULL
AP-1	NULL
site	NULL
in	NULL
maturational	NULL
induction	NULL
of	NULL
the	NULL
chicken	NULL
B-like	NULL
globin	NULL
genes	NULL
is	NULL
unknown	NULL
.	NULL

This	NULL
AP-1	NULL
site	NULL
is	NULL
relatively	NULL
inactive	NULL
alone	NULL
,	NULL
but	NULL
a	NULL
concatamer	NULL
of	NULL
three	NULL
has	NULL
60-fold	NULL
enhancing	NULL
activity	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
that	NULL
efficient	NULL
trans-activa-tion	NULL
of	NULL
a	NULL
CAT	NULL
reporter	NULL
plasmid	NULL
by	NULL
Jun-B	NULL
requires	NULL
two	NULL
or	NULL
more	NULL
adjacent	NULL
AP-1	NULL
sites	NULL
[	NULL
Chiu	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

We	NULL
speculate	NULL
that	NULL
the	NULL
close	NULL
spacing	NULL
of	NULL
AP-1	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
HS	NULL
II	NULL
enhancer	NULL
allows	NULL
formation	NULL
of	NULL
a	NULL
unique	NULL
,	NULL
highly	NULL
active	NULL
complex	NULL
.	NULL

Hemin	NULL
induction	NULL
of	NULL
K562	NULL
cells	NULL
appears	NULL
to	NULL
lead	NULL
to	NULL
complex	NULL
formation	NULL
on	NULL
the	NULL
enhancer	NULL
and	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
activity	NULL
.	NULL

Whether	NULL
this	NULL
is	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
concentration	NULL
of	NULL
proteins	NULL
available	NULL
to	NULL
bind	NULL
the	NULL
enhancer	NULL
or	NULL
to	NULL
other	NULL
changes	NULL
favoring	NULL
complex	NULL
formation	NULL
is	NULL
unresolved	NULL
.	NULL

How	NULL
could	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
influence	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
individual	NULL
globin	NULL
genes	NULL
during	NULL
development	NULL
and	NULL
erythroid	NULL
maturation	NULL
?	NULL

It	NULL
is	NULL
located	NULL
nearly	NULL
11	NULL
kb	NULL
from	NULL
the	NULL
nearest	NULL
gene	NULL
e	NULL
and	NULL
>	NULL
50	NULL
kb	NULL
from	NULL
the	NULL
most	NULL
distal	NULL
(	NULL
B	NULL
)	NULL
.	NULL

We	NULL
envision	NULL
a	NULL
model	NULL
whereby	NULL
a	NULL
loop	NULL
structure	NULL
is	NULL
formed	NULL
that	NULL
brings	NULL
the	NULL
enhancer	NULL
and	NULL
individual	NULL
promoters	NULL
into	NULL
close	NULL
proximity	NULL
through	NULL
operation	NULL
of	NULL
selector	NULL
elements	NULL
analogous	NULL
to	NULL
the	NULL
model	NULL
proposed	NULL
by	NULL
Choi	NULL
and	NULL
Engel	NULL
(	NULL
1988	NULL
)	NULL
.	NULL

In	NULL
this	NULL
model	NULL
,	NULL
enhancer	NULL
action	NULL
on	NULL
selected	NULL
promoters	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
depends	NULL
on	NULL
the	NULL
protein	NULL
and	NULL
DNA	NULL
interactions	NULL
that	NULL
result	NULL
in	NULL
formation	NULL
of	NULL
a	NULL
particular	NULL
loop	NULL
structure	NULL
bringing	NULL
the	NULL
enhancer	NULL
in	NULL
proximity	NULL
to	NULL
the	NULL
transcription	NULL
initiation	NULL
complex	NULL
.	NULL

Methods	NULL
DNA	NULL
construction	NULL
Reporter	NULL
plasmid	NULL
|	NULL
pUC007	NULL
,	NULL
a	NULL
pUC-based	NULL
plasmid	NULL
with	NULL
a	NULL
novel	NULL
polylinker	NULL
,	NULL
was	NULL
used	NULL
as	NULL
the	NULL
vector	NULL
in	NULL
these	NULL
constructions	NULL
.	NULL

pUC007	NULL
consists	NULL
of	NULL
the	NULL
following	NULL
polylinker	NULL
subcloned	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pUC9	NULL
:	NULL
Xhol	NULL
,	NULL
Bgill	NULL
,	NULL
Xbal	NULL
,	NULL
HindIII	NULL
,	NULL
Smal	NULL
,	NULL
BamHI	NULL
,	NULL
Apal	NULL
,	NULL
SphI	NULL
,	NULL
and	NULL
Sall	NULL
.	NULL

The	NULL
y-globin	NULL
promoter	NULL
was	NULL
subcloned	NULL
as	NULL
a	NULL
Hinfl	NULL
(	NULL
~	NULL
260	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
)	NULL
-Alul	NULL
(	NULL
+36	NULL
)	NULL
fragment	NULL
into	NULL
the	NULL
BgIl	NULL
and	NULL
HindIII	NULL
sites	NULL
of	NULL
pUCOO7	NULL
{	NULL
via	NULL
an	NULL
intermediate	NULL
subcloning	NULL
step	NULL
into	NULL
the	NULL
Hincll	NULL
site	NULL
of	NULL
pUC9	NULL
)	NULL
.	NULL

The	NULL
coding	NULL
region	NULL
of	NULL
the	NULL
firefly	NULL
luciferase	NULL
gene	NULL
(	NULL
pSV232ZA-LA85	NULL
'	NULL
;	NULL
DeWet	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
was	NULL
then	NULL
linked	NULL
3	NULL
'	NULL
to	NULL
the	NULL
y-globin	NULL
promoter	NULL
as	NULL
a	NULL
HindIII-BamHI	NULL
fragment	NULL
in	NULL
pUCOO7	NULL
.	NULL

This	NULL
enhancerless	NULL
plasmid	NULL
was	NULL
used	NULL
to	NULL
establish	NULL
the	NULL
level	NULL
of	NULL
reporter	NULL
gene	NULL
expression	NULL
with	NULL
a	NULL
y-globin	NULL
promoter	NULL
alone	NULL
.	NULL

An	NULL
Xhol-Aatll	NULL
fragment	NULL
Figure	NULL
7	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assays	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
An	NULL
Spl	NULL
probe	NULL
from	NULL
SV40	NULL
was	NULL
used	NULL
to	NULL
standardize	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
nuclear	NULL
extracts	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
relative	NULL
Spl-binding	NULL
activity	NULL
is	NULL
shown	NULL
at	NULL
top	NULL
.	NULL

A	NULL
46-bp	NULL
oligonucleotide	NULL
consisting	NULL
of	NULL
HS	NULL
II	NULL
sequence	NULL
(	NULL
880-926	NULL
)	NULL
,	NULL
including	NULL
the	NULL
enhancer	NULL
(	NULL
896-916	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
with	NULL
increasing	NULL
concentrations	NULL
of	NULL
uninduced	NULL
and	NULL
induced	NULL
K562	NULL
nuclear	NULL
extracts	NULL
{	NULL
lanes	NULL
3-13	NULL
)	NULL
.	NULL

{	NULL
B	NULL
)	NULL
The	NULL
HS	NULL
II	NULL
enhancer-containing	NULL
probe	NULL
described	NULL
above	NULL
was	NULL
used	NULL
as	NULL
probe	NULL
with	NULL
4.4	NULL
ug	NULL
of	NULL
uninduced	NULL
or	NULL
induced	NULL
K562	NULL
nuclear	NULL
extracts	NULL
.	NULL

Synthetic	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
unlabeled	NULL
competitors	NULL
in	NULL
200-fold	NULL
excess	NULL
.	NULL

The	NULL
NF-El	NULL
competitor	NULL
is	NULL
described	NULL
in	NULL
Methods	NULL
.	NULL

The	NULL
AP-1	NULL
competitors	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
collagenase	NULL
gene	NULL
and	NULL
SV40	NULL
and	NULL
metallothionein	NULL
II	NULL
gene	NULL
enhancers	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
HS	NULL
II	NULL
enhancer-containing	NULL
probe	NULL
(	NULL
HS	NULL
II	NULL
)	NULL
described	NULL
above	NULL
and	NULL
a	NULL
single	NULL
AP-1	NULL
site-containing	NULL
probe	NULL
(	NULL
AP-1	NULL
)	NULL
were	NULL
compared	NULL
in	NULL
alternate	NULL
lanes	NULL
.	NULL

The	NULL
latter	NULL
was	NULL
derived	NULL
from	NULL
region	NULL
II	NULL
of	NULL
the	NULL
chicken	NULL
B-globin	NULL
enhancer	NULL
.	NULL

These	NULL
probes	NULL
were	NULL
studied	NULL
against	NULL
a	NULL
panel	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
3-5	NULL
pg	NULL
per	NULL
reaction	NULL
}	NULL
and	NULL
in	NULL
vitro-synthesized	NULL
c-Jun	NULL
(	NULL
rat	NULL
}	NULL
and	NULL
c-Fos	NULL
(	NULL
rat	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
were	NULL
made	NULL
from	NULL
K562-uninduced	NULL
{	NULL
(	NULL
K562U	NULL
)	NULL
or	NULL
K562-induced	NULL
(	NULL
K5621	NULL
)	NULL
cells	NULL
,	NULL
MEL	NULL
cells	NULL
,	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
COS	NULL
cells	NULL
,	NULL
a	NULL
monkey	NULL
kidney	NULL
cell	NULL
line	NULL
.	NULL

Reticulocyte	NULL
lysate	NULL
without	NULL
added	NULL
RNA	NULL
[	NULL
NA	NULL
)	NULL
served	NULL
as	NULL
a	NULL
control	NULL
for	NULL
in	NULL
vitro-synthesized	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
.	NULL

GENES	NULL
&	NULL
DEVELOPMENT	NULL
1001	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

A.	NULL
minimal	NULL
enhancer	NULL
wild	NULL
type	NULL
C	NULL
TCA	NULL
AGCACAGCAATGC	NULL
[	NULL
T	NULL
GAGTCA	NULL
)	NULL
T	NULL
aat	NULL
GAGTCATGC	NULL
T	NULL
Ga	NULL
Gac	NULL
tta	NULL
mutant	NULL
1	NULL
A	NULL
G	NULL
T	NULL
2	NULL
3	NULL
A	NULL
CG	NULL
4	NULL
TCG	NULL
5	NULL
TCT	NULL
6	NULL
GAC	NULL
7	NULL
G	NULL
T	NULL
A	NULL
B	NULL
.	NULL

150	NULL
>	NULL
g	NULL
100	NULL
5	NULL
<	NULL
4	NULL
®	NULL
.2	NULL
s	NULL
]	NULL
®	NULL
&	NULL
so	NULL
Wild	NULL
1	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
No	NULL
Type	NULL
|	NULL
1	NULL
HSH	NULL
Enhancer	NULL
Mutants	NULL
Figure	NULL
8	NULL
.	NULL

-	NULL
Scanning	NULL
mutants	NULL
of	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
.	NULL

The	NULL
wild-type	NULL
and	NULL
mutant	NULL
enhancers	NULL
were	NULL
synthesized	NULL
as	NULL
46-bp	NULL
oligonucleotides	NULL
,	NULL
subcloned	NULL
into	NULL
the	NULL
reporter	NULL
plasmid	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
enhancing	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
wild-type	NULL
46-bp	NULL
fragment	NULL
containing	NULL
the	NULL
HS	NULL
II	NULL
enhancer	NULL
is	NULL
shown	NULL
at	NULL
top	NULL
.	NULL

Tandem	NULL
AP-1-binding	NULL
sites	NULL
are	NULL
boxed	NULL
.	NULL

Seven	NULL
mutants	NULL
scanning	NULL
the	NULL
enhancer	NULL
in	NULL
3-bp	NULL
intervals	NULL
are	NULL
shown	NULL
beneath	NULL
the	NULL
46-bp	NULL
wild-type	NULL
sequence	NULL
.	NULL

Only	NULL
mutant	NULL
7	NULL
falls	NULL
completely	NULL
outside	NULL
both	NULL
AP-1-binding	NULL
sites	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activity	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
enhancers	NULL
is	NULL
shown	NULL
relative	NULL
to	NULL
an	NULL
enhancerless	NULL
reporter	NULL
plasmid	NULL
(	NULL
no	NULL
HS	NULL
II	NULL
)	NULL
in	NULL
uninduced	NULL
{	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
induced	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
with	NULL
induction	NULL
is	NULL
shown	NULL
for	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
enhancers	NULL
over	NULL
the	NULL
solid	NULL
bars	NULL
.	NULL

Each	NULL
was	NULL
assayed	NULL
in	NULL
duplicate	NULL
and	NULL
normalized	NULL
based	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
cotransfected	NULL
B19-CAT	NULL
reporter	NULL
construct	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

of	NULL
this	NULL
plasmid	NULL
containing	NULL
the	NULL
chimeric	NULL
y-globin	NULL
promoter/luciferase	NULL
gene	NULL
,	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Sall	NULL
and	NULL
Aatll	NULL
sites	NULL
of	NULL
pUC0O07	NULL
,	NULL
3	NULL
of	NULL
various	NULL
mutants	NULL
of	NULL
HS	NULL
IL	NULL
.	NULL

This	NULL
strategy	NULL
allowed	NULL
for	NULL
the	NULL
rapid	NULL
construction	NULL
and	NULL
testing	NULL
of	NULL
mutants	NULL
of	NULL
HS	NULL
IL	NULL
Truncation	NULL
mutants	NULL
of	NULL
HS	NULL
II	NULL
HS	NULL
II	NULL
was	NULL
subcloned	NULL
as	NULL
a	NULL
KpnI	NULL
(	NULL
blunted	NULL
}	NULL
|-Bg/II	NULL
fragment	NULL
into	NULL
the	NULL
Bg/lI	NULL
(	NULL
blunted	NULL
)	NULL
and	NULL
BamHI	NULL
sites	NULL
of	NULL
pUCO07	NULL
(	NULL
pUCO07-HS	NULL
II	NULL
)	NULL
.	NULL

Truncation	NULL
mutants	NULL
of	NULL
HS	NULL
II	NULL
were	NULL
made	NULL
by	NULL
exonuclease	NULL
III	NULL
digestion	NULL
from	NULL
either	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
``	NULL
end	NULL
of	NULL
HS	NULL
II	NULL
.	NULL

A	NULL
modification	NULL
of	NULL
the	NULL
Erase-a-Base	NULL
protocol	NULL
(	NULL
Pro-mega	NULL
}	NULL
was	NULL
used	NULL
.	NULL

Truncations	NULL
(	NULL
3	NULL
'	NULL
)	NULL
were	NULL
made	NULL
as	NULL
follows	NULL
:	NULL
40	NULL
ug	NULL
of	NULL
pUCO07-HS	NULL
II	NULL
DNA	NULL
was	NULL
linearized	NULL
at	NULL
the	NULL
Sall	NULL
site	NULL
,	NULL
phenol/	NULL
chloroform-extracted	NULL
,	NULL
ethanol-precipitated	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
450	NULL
pl	NULL
of	NULL
buffer	NULL
[	NULL
66	NULL
mm	NULL
TrisHCHI	NULL
and	NULL
0.66	NULL
mm	NULL
MgCl	NULL
,	NULL
(	NULL
pH	NULL
8.0	NULL
}	NULL
]	NULL
.	NULL

The	NULL
linearized	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
3000	NULL
units	NULL
of	NULL
exonuclease	NULL
III	NULL
at	NULL
32°C	NULL
for	NULL
6	NULL
min	NULL
.	NULL

At	NULL
30-sec	NULL
intervals	NULL
,	NULL
aliquots	NULL
{	NULL
12	NULL
total	NULL
)	NULL
were	NULL
taken	NULL
and	NULL
added	NULL
to	NULL
108	NULL
pl	NULL
of	NULL
S1	NULL
buffer	NULL
with	NULL
30	NULL
units	NULL
of	NULL
S1	NULL
nuclease	NULL
,	NULL
on	NULL
ice	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
incubated	NULL
with	NULL
S1	NULL
nuclease	NULL
at	NULL
25°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

S1	NULL
nuclease	NULL
was	NULL
inactivated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
14	NULL
pl	NULL
of	NULL
S1	NULL
stop	NULL
buffer	NULL
and	NULL
incubation	NULL
at	NULL
70°C	NULL
for	NULL
10	NULL
min	NULL
.	NULL

To	NULL
blunt	NULL
the	NULL
truncated	NULL
ends	NULL
,	NULL
14	NULL
wl	NULL
of	NULL
Klenow	NULL
buffer	NULL
,	NULL
containing	NULL
2.5	NULL
units	NULL
of	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
and	NULL
14	NULL
l	NULL
of	NULL
0.125	NULL
mm	NULL
dATP	NULL
,	NULL
dCTP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
dTTP	NULL
,	NULL
was	NULL
added	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
purified	NULL
by	NULL
using	NULL
Gene	NULL
Clean	NULL
(	NULL
Bio	NULL
101	NULL
)	NULL
and	NULL
digested	NULL
with	NULL
Xhol	NULL
.	NULL

The	NULL
3'-truncated	NULL
HS	NULL
II	NULL
fragments	NULL
were	NULL
then	NULL
gel-purified	NULL
1002	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
and	NULL
subcloned	NULL
as	NULL
an	NULL
Xhol-blunted	NULL
fragment	NULL
into	NULL
pUCOO7	NULL
opened	NULL
at	NULL
the	NULL
Xhol	NULL
and	NULL
Smal	NULL
sites	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
3	NULL
'	NULL
truncation	NULL
was	NULL
determined	NULL
precisely	NULL
by	NULL
sequencing	NULL
.	NULL

Truncation	NULL
mutants	NULL
(	NULL
5	NULL
'	NULL
)	NULL
were	NULL
made	NULL
in	NULL
the	NULL
same	NULL
way	NULL
,	NULL
except	NULL
pUCOO7-HS	NULL
II	NULL
was	NULL
initially	NULL
opened	NULL
at	NULL
the	NULL
Xhol	NULL
site	NULL
and	NULL
truncation	NULL
mutants	NULL
were	NULL
subcloned	NULL
as	NULL
a	NULL
Sail-blunted	NULL
fragment	NULL
into	NULL
pUCOO7	NULL
opened	NULL
at	NULL
Sall	NULL
and	NULL
Smal	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
the	NULL
55	NULL
truncation	NULL
was	NULL
determined	NULL
by	NULL
restriction	NULL
mapping	NULL
.	NULL

Scrambled	NULL
enhancer	NULL
construct	NULL
An	NULL
enh~	NULL
version	NULL
of	NULL
HS	NULL
II	NULL
was	NULL
made	NULL
by	NULL
replacing	NULL
16	NULL
of	NULL
the	NULL
20	NULL
bp	NULL
of	NULL
the	NULL
enhancer	NULL
with	NULL
polylinker	NULL
from	NULL
a	NULL
3	NULL
'	NULL
truncation	NULL
mutant	NULL
of	NULL
HS	NULL
II	NULL
.	NULL

An	NULL
oligonucleotide	NULL
was	NULL
synthesized	NULL
(	NULL
924-974	NULL
)	NULL
,	NULL
consisting	NULL
of	NULL
wild-type	NULL
HS	NULL
II	NULL
sequence	NULL
from	NULL
932	NULL
to	NULL
974	NULL
,	NULL
with	NULL
HindIII	NULL
and	NULL
Xhol	NULL
sites	NULL
on	NULL
the	NULL
5	NULL
'	NULL
end	NULL
and	NULL
an	NULL
EcoRI	NULL
site	NULL
on	NULL
the	NULL
3	NULL
'	NULL
end	NULL
.	NULL

This	NULL
oligonucleotide	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
HindIII	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
pUC9	NULL
,	NULL
sequenced	NULL
,	NULL
and	NULL
cut	NULL
out	NULL
again	NULL
as	NULL
an	NULL
Xhol-Aatll	NULL
fragment	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
Sall	NULL
and	NULL
AatlI	NULL
sites	NULL
of	NULL
pUCOO07	NULL
downstream	NULL
of	NULL
a	NULL
3	NULL
'	NULL
truncation	NULL
mutant	NULL
,	NULL
consisting	NULL
of	NULL
wild-type	NULL
HS	NULL
II	NULL
sequence	NULL
from	NULL
nucleotide	NULL
1	NULL
to	NULL
900	NULL
and	NULL
a	NULL
polylinker	NULL
sequence	NULL
from	NULL
901	NULL
to	NULL
923	NULL
.	NULL

This	NULL
plasmid	NULL
was	NULL
opened	NULL
at	NULL
PpuM1	NULL
and	NULL
Aatli	NULL
,	NULL
and	NULL
a	NULL
wild-type	NULL
HS	NULL
II	NULL
sequence	NULL
from	NULL
975	NULL
to	NULL
1455	NULL
was	NULL
subcloned	NULL
in	NULL
as	NULL
a	NULL
fragment	NULL
.	NULL

This	NULL
construct	NULL
effectively	NULL
replaced	NULL
wild-type	NULL
HS	NULL
II	NULL
sequence	NULL
901-931	NULL
with	NULL
polylinker	NULL
.	NULL

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
K562	NULL
Induced	NULL
Enhancer	NULL
Mutants	NULL
wild	NULL
Probe	NULL
:	NULL
Type	NULL
1	NULL
'	NULL
2	NULL
3	NULL
:	NULL
4	NULL
5	NULL
6	NULL
7	NULL
wih	NULL
win	NULL
«	NULL
e	NULL
«	NULL
m	NULL
'	NULL
``	NULL
HHMI	NULL
e	NULL
Hela	NULL
Enhancer	NULL
Mutants	NULL
Wild	NULL
Probe	NULL
:	NULL
Type	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
.	NULL

7	NULL
al	NULL
m	NULL
||	NULL
twat	NULL
b	NULL
[	NULL
bood	NULL
bud	NULL
Wiad	NULL
bib	NULL
Figure	NULL
9	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assays	NULL
of	NULL
enhancer	NULL
mutants	NULL
.	NULL

Assays	NULL
were	NULL
done	NULL
by	NULL
use	NULL
of	NULL
the	NULL
wild-type	NULL
and	NULL
mutant	NULL
enhancer	NULL
probes	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
induced	NULL
K562	NULL
nuclear	NULL
extract	NULL
(	NULL
4.7	NULL
pg	NULL
,	NULL
top	NULL
)	NULL
or	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
(	NULL
3.4	NULL
ug	NULL
,	NULL
bottom	NULL
}	NULL
.	NULL

Oligonucleotides	NULL
Oligonucleotides	NULL
were	NULL
synthesized	NULL
on	NULL
an	NULL
Applied	NULL
Biosystems	NULL
DNA	NULL
Synthesizer	NULL
model	NULL
380B	NULL
,	NULL
by	NULL
use	NULL
of	NULL
phosphoramidite	NULL
chemistry	NULL
.	NULL

The	NULL
oligonucleotides	NULL
were	NULL
purified	NULL
on	NULL
OPC	NULL
cartridges	NULL
(	NULL
Applied	NULL
Biosystems	NULL
}	NULL
.	NULL

Prior	NULL
to	NULL
subcloning	NULL
or	NULL
use	NULL
as	NULL
com-petitors	NULL
,	NULL
complementary	NULL
strands	NULL
were	NULL
annealed	NULL
in	NULL
a	NULL
buffer	NULL
of	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mm	NULL
NaCl	NULL
,	NULL
and	NULL
10	NULL
mm	NULL
MgCl	NULL
,	NULL
by	NULL
heating	NULL
to	NULL
95°C	NULL
for	NULL
2	NULL
min	NULL
and	NULL
cooling	NULL
to	NULL
room	NULL
temperature	NULL
for	NULL
>	NULL
1	NULL
hr	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
made	NULL
with	NULL
5	NULL
HindIII	NULL
and	NULL
3	NULL
'	NULL
BamHI	NULL
ends	NULL
.	NULL

They	NULL
were	NULL
subconed	NULL
into	NULL
these	NULL
sites	NULL
of	NULL
pUCOO7	NULL
and	NULL
sequenced	NULL
by	NULL
the	NULL
chain-termination	NULL
method	NULL
(	NULL
Sequenase	NULL
,	NULL
U.S.	NULL
Biochemical	NULL
)	NULL
(	NULL
Smith	NULL
1980	NULL
)	NULL
.	NULL

The	NULL
chimeric	NULL
y-globin	NULL
promoter/luciferase	NULL
reporter	NULL
gene	NULL
was	NULL
inserted	NULL
into	NULL
the	NULL
Sall	NULL
and	NULL
Aatll	NULL
sites	NULL
of	NULL
these	NULL
plasmids	NULL
as	NULL
an	NULL
Xhol-AatlI	NULL
fragment	NULL
.	NULL

Tissue	NULL
culture	NULL
and	NULL
cell	NULL
transfections	NULL
Human	NULL
erythroleukemia	NULL
K562	NULL
cells	NULL
and	NULL
adherent	NULL
HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
improved	NULL
minimal	NULL
essential	NULL
medium	NULL
(	NULL
IMEM	NULL
,	NULL
Biofluids	NULL
]	NULL
)	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
prepared	NULL
by	NULL
Triton	NULL
X-100	NULL
lysis	NULL
and	NULL
purification	NULL
over	NULL
two	NULL
cesium	NULL
chloride	NULL
gradients	NULL
.	NULL

Plasmid	NULL
DNA	NULL
was	NULL
introduced	NULL
into	NULL
K562	NULL
cells	NULL
in	NULL
log	NULL
phase	NULL
growth	NULL
by	NULL
electroporation	NULL
[	NULL
Potter	NULL
et	NULL
al	NULL
.	NULL

1984	NULL
]	NULL
by	NULL
use	NULL
of	NULL
a	NULL
Bio-Rad	NULL
gene	NULL
pulser	NULL
apparatus	NULL
.	NULL

Adherent	NULL
Hela	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
precipitation	NULL
method	NULL
{	NULL
(	NULL
Wigler	NULL
et	NULL
al	NULL
.	NULL

1978	NULL
)	NULL
.	NULL

A	NULL
constant	NULL
amount	NULL
of	NULL
an	NULL
internal	NULL
control	NULL
plasmid	NULL
,	NULL
B19-CAT	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
T.	NULL
Shimada	NULL
}	NULL
,	NULL
containing	NULL
the	NULL
B19	NULL
parvovirus	NULL
promoter	NULL
driving	NULL
the	NULL
bacterial	NULL
CAT	NULL
gene	NULL
,	NULL
was	NULL
included	NULL
in	NULL
all	NULL
transfections	NULL
to	NULL
normalize	NULL
the	NULL
luciferase	NULL
data	NULL
.	NULL

To	NULL
transfect	NULL
K562	NULL
cells	NULL
,	NULL
4.0	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
a	NULL
total	NULL
of	NULL
40	NULL
ug	NULL
of	NULL
supercoiled	NULL
plasmid	NULL
DNA	NULL
in	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
400	NULL
wl	NULL
and	NULL
electroporated	NULL
at	NULL
settings	NULL
of	NULL
0.20	NULL
V	NULL
and	NULL
960	NULL
uF	NULL
.	NULL

The	NULL
AP-1	NULL
sites	NULL
in	NULL
DCR	NULL
function	NULL
as	NULL
inducible	NULL
enhancer	NULL
40	NULL
ug	NULL
of	NULL
plasmid	NULL
consisted	NULL
of	NULL
32	NULL
ug	NULL
of	NULL
test	NULL
plasmid	NULL
and	NULL
8	NULL
pg	NULL
of	NULL
B19-CAT	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
16	NULL
ug	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
construct	NULL
and	NULL
4	NULL
pg	NULL
of	NULL
BI9-CAT	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
transient	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

Hemin	NULL
induction	NULL
(	NULL
20	NULL
wm	NULL
}	NULL
was	NULL
initiated	NULL
24	NULL
hr	NULL
prior	NULL
to	NULL
transfection	NULL
and	NULL
continued	NULL
for	NULL
48	NULL
hr	NULL
afterward	NULL
for	NULL
a	NULL
total	NULL
of	NULL
72	NULL
hr	NULL
{	NULL
Lloyd	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
]	NULL
.	NULL

Transient	NULL
assays	NULL
Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
{	NULL
deWet	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
;	NULL
Nelson	NULL
et	NULL
al	NULL
.	NULL

1988	NULL
)	NULL
on	NULL
a	NULL
Monolight	NULL
2001	NULL
luminometer	NULL
{	NULL
Analytical	NULL
Luminescence	NULL
Laboratories	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
assay	NULL
was	NULL
linear	NULL
from	NULL
1000	NULL
to	NULL
100,000	NULL
light	NULL
units	NULL
.	NULL

Samples	NULL
giving	NULL
values	NULL
>	NULL
100,000	NULL
light	NULL
units	NULL
were	NULL
diluted	NULL
,	NULL
reassayed	NULL
,	NULL
and	NULL
corrected	NULL
for	NULL
dilution	NULL
by	NULL
the	NULL
appropriate	NULL
factor	NULL
.	NULL

CAT	NULL
activity	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
scintillation	NULL
vial	NULL
assay	NULL
(	NULL
Neumann	NULL
et	NULL
al	NULL
.	NULL

1987	NULL
)	NULL
by	NULL
use	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
-butyryl	NULL
Coenzyme	NULL
A	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
as	NULL
substrate	NULL
.	NULL

Primer	NULL
extension	NULL
assay	NULL
Primer	NULL
extension	NULL
off	NULL
of	NULL
the	NULL
y-globin	NULL
primer	NULL
{	NULL
CCTCCTCTGT-GAAATGACCCATGCGC	NULL
]	NULL
or	NULL
the	NULL
luciferase	NULL
primer	NULL
(	NULL
GATGTT-CACCTCGATATGTGC	NULL
)	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Phelps	NULL
and	NULL
Howley	NULL
[	NULL
1987	NULL
]	NULL
.	NULL

Analysis	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
Nuclear	NULL
extracts	NULL
|	NULL
Cells	NULL
were	NULL
cultured	NULL
in	NULL
suspension	NULL
in	NULL
micro-cartier	NULL
flasks	NULL
(	NULL
Wheaton	NULL
)	NULL
and	NULL
harvested	NULL
in	NULL
late	NULL
log	NULL
phase	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Dignam	NULL
(	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

1983	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMSF	NULL
,	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
,	NULL
and	NULL
leu-peptin	NULL
.	NULL

The	NULL
extract	NULL
was	NULL
dialyzed	NULL
against	NULL
a	NULL
buffer	NULL
(	NULL
buffer	NULL
D	NULL
)	NULL
composed	NULL
of	NULL
20	NULL
mm	NULL
HEPES	NULL
[	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
100	NULL
mm	NULL
KCI	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
mm	NULL
DTT	NULL
,	NULL
0.5	NULL
mm	NULL
PMSF	NULL
,	NULL
and	NULL
20	NULL
%	NULL
glycerol	NULL
and	NULL
stored	NULL
in	NULL
small	NULL
aliquots	NULL
at	NULL
-	NULL
70°C	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
Bradford	NULL
1976	NULL
)	NULL
,	NULL
with	NULL
a	NULL
kit	NULL
from	NULL
Bio-Rad	NULL
and	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
a	NULL
standard	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
was	NULL
generally	NULL
5-6	NULL
mg/ral	NULL
.	NULL

Hemin-induced	NULL
K562	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
hemin	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
(	NULL
20	NULL
wm	NULL
final	NULL
concentration	NULL
)	NULL
36	NULL
hr	NULL
prior	NULL
to	NULL
harvest	NULL
.	NULL

In	NULL
vitro-synthesized	NULL
c-Jun	NULL
(	NULL
rat	NULL
)	NULL
and	NULL
c-Fos	NULL
(	NULL
rat	NULL
)	NULL
-	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
were	NULL
provided	NULL
by	NULL
Frank	NULL
Rauscher	NULL
and	NULL
Tom	NULL
Curran	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
association	NULL
of	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
and	NULL
reaction	NULL
conditions	NULL
for	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
have	NULL
been	NULL
described	NULL
by	NULL
Rauscher	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
.	NULL

DNase	NULL
I	NULL
protection	NULL
assay	NULL
-	NULL
Probes	NULL
for	NULL
the	NULL
DNase	NULL
I	NULL
protection	NULL
assay	NULL
were	NULL
made	NULL
from	NULL
pUCOO7-HS	NULL
II	NULL
and	NULL
pUCOO7-HS	NULL
II	NULL
enh	NULL
-	NULL
.	NULL

These	NULL
plasmids	NULL
were	NULL
linearized	NULL
at	NULL
PpuM1	NULL
(	NULL
974	NULL
)	NULL
and	NULL
end-labeled	NULL
with	NULL
polynucleotide	NULL
kinase	NULL
[	NULL
lower	NULL
strand	NULL
)	NULL
or	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
(	NULL
upper	NULL
strand	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
released	NULL
by	NULL
digestion	NULL
with	NULL
HindIII	NULL
and	NULL
purified	NULL
from	NULL
agarose	NULL
by	NULL
Gene	NULL
Clean	NULL
.	NULL

Each	NULL
footprint	NULL
reaction	NULL
(	NULL
Jones	NULL
et	NULL
al	NULL
.	NULL

1985	NULL
)	NULL
contained	NULL
10,000	NULL
cpm	NULL
of	NULL
end-labeled	NULL
probe	NULL
,	NULL
varying	NULL
amounts	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
poly	NULL
{	NULL
d	NULL
{	NULL
I-C	NULL
)	NULL
]	NULL
,	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
30	NULL
wl	NULL
.	NULL

The	NULL
final	NULL
ionic	NULL
composition	NULL
was	NULL
20	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
60	NULL
mm	NULL
KCl	NULL
,	NULL
0.2	NULL
mm	NULL
EDTA	NULL
,	NULL
1.3	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
0.5	NULL
mm	NULL
DTT	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
6	NULL
%	NULL
polyethylene	NULL
glycol	NULL
(	NULL
avg	NULL
.	NULL

M	NULL
,	NULL
8000	NULL
)	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
15	NULL
min	NULL
,	NULL
followed	NULL
by	NULL
25°C	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
adding	NULL
CaCl	NULL
,	NULL
and	NULL
MgCl	NULL
,	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
3	NULL
mM	NULL
,	NULL
DNase	NULL
I	NULL
digestion	NULL
was	NULL
performed	NULL
at	NULL
25°C	NULL
for	NULL
1	NULL
min	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
DNase	NULL
I	NULL
used	NULL
in	NULL
each	NULL
reaction	NULL
was	NULL
the	NULL
amount	NULL
needed	NULL
to	NULL
give	NULL
equivalent	NULL
degrees	NULL
of	NULL
probe	NULL
digestion	NULL
.	NULL

The	NULL
reaction	NULL
was	NULL
termi-	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1003	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

nated	NULL
with	NULL
a	NULL
stop	NULL
buffer	NULL
containing	NULL
EDTA	NULL
,	NULL
SDS	NULL
,	NULL
and	NULL
proteinase	NULL
K.	NULL
Proteinase	NULL
K	NULL
digestion	NULL
proceeded	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
extracted	NULL
twice	NULL
with	NULL
phenol/chloroform	NULL
,	NULL
precipitated	NULL
twice	NULL
with	NULL
ethanol	NULL
,	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
sequencing	NULL
gel	NULL
.	NULL

In	NULL
situ	NULL
phenanthroline/copper	NULL
footprinting	NULL
After	NULL
gel	NULL
mobility-shift	NULL
assay	NULL
,	NULL
as	NULL
described	NULL
below	NULL
,	NULL
in	NULL
situ	NULL
phenanthroline/	NULL
copper	NULL
footprinting	NULL
was	NULL
performed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Kuwabara	NULL
and	NULL
Sigman	NULL
(	NULL
1987	NULL
)	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assay	NULL
The	NULL
HS	NULL
II	NULL
enhancer	NULL
and	NULL
chicken	NULL
B	NULL
enhancer	NULL
probes	NULL
were	NULL
prepared	NULL
from	NULL
oligonucleotides	NULL
subcloned	NULL
into	NULL
pUCO07	NULL
,	NULL
released	NULL
by	NULL
HindIII	NULL
and	NULL
BamHI	NULL
digestion	NULL
,	NULL
labeled	NULL
with	NULL
Klenow	NULL
DNA	NULL
polymerase	NULL
,	NULL
and	NULL
purified	NULL
over	NULL
12	NULL
%	NULL
acrylamide	NULL
gels	NULL
.	NULL

The	NULL
SV40	NULL
(	NULL
Spl	NULL
)	NULL
probe	NULL
was	NULL
provided	NULL
by	NULL
Todd	NULL
Evans	NULL
and	NULL
Gary	NULL
Felsenfeld	NULL
.	NULL

Gel	NULL
mobility-shift	NULL
assays	NULL
were	NULL
performed	NULL
(	NULL
Fried	NULL
and	NULL
Crothers	NULL
1981	NULL
;	NULL
Strauss	NULL
and	NULL
Varshavsky	NULL
1984	NULL
]	NULL
with	NULL
20,000	NULL
cpm	NULL
of	NULL
probe	NULL
added	NULL
last	NULL
to	NULL
a	NULL
20-ul	NULL
reaction	NULL
containing	NULL
varying	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
poly	NULL
[	NULL
d	NULL
{	NULL
I-C	NULL
)	NULL
]	NULL
.	NULL

The	NULL
final	NULL
ionic	NULL
conditions	NULL
were	NULL
identical	NULL
to	NULL
the	NULL
footprint	NULL
assay	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
Double-stranded	NULL
synthetic	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
cold	NULL
competitors	NULL
in	NULL
some	NULL
reactions	NULL
and	NULL
were	NULL
added	NULL
with	NULL
the	NULL
probe	NULL
.	NULL

A	NULL
1000-fold	NULL
excess	NULL
of	NULL
self-competitors	NULL
and	NULL
200-fold	NULL
excess	NULL
of	NULL
AP-1	NULL
competitors	NULL
were	NULL
used	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
25°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
the	NULL
samples	NULL
were	NULL
run	NULL
on	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
buffer	NULL
for	NULL
90	NULL
min	NULL
at	NULL
10	NULL
V/cm	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
for	NULL
~6	NULL
hr	NULL
.	NULL

Probes	NULL
The	NULL
single	NULL
AP-1	NULL
site	NULL
probe	NULL
was	NULL
derived	NULL
from	NULL
region	NULL
II	NULL
of	NULL
the	NULL
chicken	NULL
-globin	NULL
enhancer	NULL
(	NULL
Mignotte	NULL
et	NULL
al	NULL
.	NULL

1989b	NULL
)	NULL
.	NULL

AP-1-	NULL
and	NULL
Spl-binding	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

HS	NULL
II	NULL
enhancer	NULL
(	NULL
AP-1	NULL
)	NULL
:	NULL
CTCAAGCACAGCAATGCTGAGTC	NULL
ATGATGAGTCATGCTGAGGCTTA	NULL
TCCCCGAAGCGAGCTGAC	NULL
TCATGCTAGCCCAGCAG	NULL
AATTGCAGAGCTGGGAATCCTAACT	NULL
GGGCGGAGTTATGCTGCTCCTCTGG	NULL
Chicken	NULL
B-globin	NULL
enhancer	NULL
[	NULL
AP-1	NULL
}	NULL
:	NULL
$	NULL
¥40	NULL
(	NULL
Spl	NULL
)	NULL
:	NULL
Competitors	NULL
The	NULL
NF-El	NULL
competitor	NULL
consisted	NULL
of	NULL
the	NULL
-199	NULL
to	NULL
-163	NULL
region	NULL
of	NULL
y-globin	NULL
gene	NULL
promoter	NULL
that	NULL
contains	NULL
a	NULL
T-	NULL
»	NULL
C	NULL
substitution	NULL
at	NULL
position	NULL
-175	NULL
.	NULL

This	NULL
region	NULL
contains	NULL
two	NULL
binding	NULL
sites	NULL
for	NULL
NF-El	NULL
and	NULL
one	NULL
for	NULL
the	NULL
octamer-binding	NULL
protein	NULL
.	NULL

The	NULL
-175	NULL
T-	NULL
C	NULL
mutation	NULL
ablates	NULL
octamer	NULL
binding	NULL
but	NULL
leaves	NULL
NF-E1	NULL
binding	NULL
intact	NULL
(	NULL
Tsai	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
)	NULL
.	NULL

Only	NULL
the	NULL
AP-1	NULL
consensus	NULL
sequence	NULL
and	NULL
1	NULL
nucleotide	NULL
on	NULL
either	NULL
side	NULL
matches	NULL
the	NULL
actual	NULL
sequence	NULL
of	NULL
the	NULL
collagenase	NULL
gene	NULL
enhancer	NULL
.	NULL

AP-1-and	NULL
NF-El-binding	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

Collagenase	NULL
gene	NULL
enhancer	NULL
{	NULL
AP-1	NULL
}	NULL
:	NULL
AGCTTATCGATTT	NULL
GATGAGTCAGCCG	NULL
5¥40	NULL
enhancer	NULL
[	NULL
AP-1	NULL
)	NULL
:	NULL
AGCTTATCTCAA	NULL
TTAGTCAGCAAG	NULL
Metallothioncin	NULL
II	NULL
{	NULL
AP-1	NULL
}	NULL
:	NULL
AGCTTCGCGCTGAGTCAC	NULL
GATGCGCGCTGAGTCACG	NULL
-175	NULL
T	NULL
+C	NULL
y-globin	NULL
promoter	NULL
(	NULL
NF-E1	NULL
}	NULL
:	NULL
TTCCCCACACTATCTCAAT	NULL
GCAAACATCTGTCTGAAA	NULL
Acknowledgments	NULL
We	NULL
thank	NULL
David	NULL
Bodine	NULL
for	NULL
providing	NULL
pUCO007	NULL
,	NULL
Chris	NULL
Lowrey	NULL
for	NULL
providing	NULL
the	NULL
K562	NULL
and	NULL
MEL	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
Amanda	NULL
Cline	NULL
for	NULL
the	NULL
5	NULL
'	NULL
truncations	NULL
of	NULL
HS	NULL
II	NULL
,	NULL
Frank	NULL
Rauscher	NULL
and	NULL
Tom	NULL
Curran	NULL
for	NULL
in	NULL
vitro-synthesized	NULL
c-Jun	NULL
and	NULL
c-Fos	NULL
,	NULL
and	NULL
Todd	NULL
Evans	NULL
and	NULL
Gary	NULL
Felsenfeld	NULL
for	NULL
the	NULL
SV40	NULL
(	NULL
Spl	NULL
)	NULL
probe	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
David	NULL
Bodine	NULL
and	NULL
Robert	NULL
Redner	NULL
for	NULL
their	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
1004	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
manuscript	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
David	NULL
Trauber	NULL
for	NULL
first	NULL
pointing	NULL
out	NULL
the	NULL
AP-1-binding	NULL
sequences	NULL
in	NULL
the	NULL
enhancer	NULL
.	NULL

References	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
I.	NULL
Baumann	NULL
,	NULL
B.	NULL
Stein	NULL
,	NULL
H.	NULL
Delius	NULL
,	NULL
H.J	NULL
.	NULL

Rahmsdorf	NULL
,	NULL
and	NULL
P.	NULL
Herrlich	NULL
.	NULL

1987	NULL
.	NULL

12-O-Tetradecanoyl-phorbol-13-acetate	NULL
induction	NULL
of	NULL
the	NULL
human	NULL
collagenase	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
an	NULL
inducible	NULL
enhancer	NULL
element	NULL
located	NULL
in	NULL
the	NULL
5'-flanking	NULL
region	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
:	NULL
2256-2266	NULL
.	NULL

Antoniou	NULL
,	NULL
M.	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
G.	NULL
Habets	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
gene	NULL
contains	NULL
multiple	NULL
regulatory	NULL
regions	NULL
:	NULL
Identification	NULL
of	NULL
one	NULL
promoter	NULL
and	NULL
two	NULL
downstream	NULL
enhancers	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7	NULL
:	NULL
377-384	NULL
.	NULL

Bartha	NULL
,	NULL
E.	NULL
,	NULL
E.	NULL
Olah	NULL
,	NULL
J.G	NULL
.	NULL

Szelenyi	NULL
,	NULL
and	NULL
S.R	NULL
.	NULL

Hollan	NULL
.	NULL

1987	NULL
.	NULL

Characterization	NULL
of	NULL
'	NULL
``	NULL
fetal-type	NULL
``	NULL
acetylcholinesterase	NULL
in	NULL
hemin-treated	NULL
K562	NULL
cell	NULL
cultures	NULL
.	NULL

Blood	NULL
Cells	NULL
12	NULL
:	NULL
647-655	NULL
.	NULL

Behringer	NULL
,	NULL
RR	NULL
.	NULL

,	NULL
RE	NULL
.	NULL

Hammer	NULL
,	NULL
RL	NULL
.	NULL

Brinster	NULL
,	NULL
R.D	NULL
.	NULL

Palmiter	NULL
,	NULL
and	NULL
TM	NULL
.	NULL

Townes	NULL
.	NULL

1987	NULL
.	NULL

Two	NULL
3	NULL
'	NULL
sequences	NULL
direct	NULL
adult	NULL
erythroid-specific	NULL
expression	NULL
of	NULL
human	NULL
-globin	NULL
genes	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

841	NULL
7056-7060	NULL
.	NULL

Blom	NULL
van	NULL
Assendelft	NULL
,	NULL
G.	NULL
,	NULL
O.	NULL
Hanscombe	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Greaves	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
B-globin	NULL
dominant	NULL
control	NULL
region	NULL
activates	NULL
homologous	NULL
and	NULL
heterologous	NULL
promoters	NULL
in	NULL
a	NULL
tissue-specific	NULL
manner	NULL
.	NULL

Cell	NULL
56	NULL
:	NULL
969-977	NULL
.	NULL

Bodine	NULL
,	NULL
D.M	NULL
.	NULL

and	NULL
TJ	NULL
.	NULL

Ley	NULL
.	NULL

1987	NULL
.	NULL

An	NULL
enhancer	NULL
element	NULL
lies	NULL
3	NULL
'	NULL
to	NULL
the	NULL
human	NULL
*y	NULL
globin	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6	NULL
:	NULL
2997-3004	NULL
.	NULL

Bohmann	NULL
,	NULL
D.	NULL
,	NULL
TJ	NULL
.	NULL

Bos	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
T.	NULL
Nishimura	NULL
,	NULL
P.K	NULL
.	NULL

Vogt	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
proto-oncogene	NULL
c-jun	NULL
encodes	NULL
a	NULL
DNA	NULL
binding	NULL
protein	NULL
with	NULL
structural	NULL
and	NULL
functional	NULL
properties	NULL
of	NULL
transcription	NULL
factor	NULL
AP-1	NULL
.	NULL

Science	NULL
238	NULL
:	NULL
1386-1392	NULL
.	NULL

Bradford	NULL
,	NULL
M.M	NULL
.	NULL

1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantitation	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
using	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72	NULL
:	NULL
248-254	NULL
.	NULL

Catala	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
G.	NULL
Habets	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1989	NULL
.	NULL

Nuclear	NULL
protein	NULL
factors	NULL
and	NULL
erythroid	NULL
transcription	NULL
of	NULL
the	NULL
human	NULL
*4y-globin	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
:	NULL
3811-3827	NULL
.	NULL

Caubet	NULL
,	NULL
JF	NULL
.	NULL

,	NULL
M.T	NULL
.	NULL

Mitjavila	NULL
,	NULL
A.	NULL
Dubart	NULL
,	NULL
D.	NULL
Roten	NULL
,	NULL
S.C.	NULL
Weil	NULL
,	NULL
and	NULL
W.	NULL
Vainchenker	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
c-fos	NULL
proto-oncogene	NULL
by	NULL
human	NULL
and	NULL
murine	NULL
erythroblasts	NULL
.	NULL

Blood	NULL
74	NULL
:	NULL
947-951	NULL
.	NULL

Chao	NULL
,	NULL
M.V	NULL
.	NULL

,	NULL
P.	NULL
Mellon	NULL
,	NULL
P.	NULL
Chamey	NULL
,	NULL
T.	NULL
Maniatis	NULL
,	NULL
and	NULL
R.	NULL
Axel	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
regulated	NULL
expression	NULL
of	NULL
B-globin	NULL
genes	NULL
introduced	NULL
into	NULL
mouse	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Cell	NULL
32	NULL
:	NULL
483-493	NULL
.	NULL

Chiu	NULL
,	NULL
R.	NULL
,	NULL
P.	NULL
Angel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Jun-B	NULL
differs	NULL
in	NULL
its	NULL
biological	NULL
properties	NULL
from	NULL
,	NULL
and	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
,	NULL
c-jun	NULL
.	NULL

Cell	NULL
59	NULL
:	NULL
979-986	NULL
.	NULL

Choi	NULL
,	NULL
O.R	NULL
.	NULL

and	NULL
J.D	NULL
.	NULL

Engel	NULL
.	NULL

1988	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
B-globin	NULL
gene	NULL
switching	NULL
.	NULL

Cell	NULL
55	NULL
:	NULL
17-26	NULL
.	NULL

Cohen	NULL
,	NULL
D.R	NULL
.	NULL

,	NULL
P.C	NULL
.	NULL

Ferreira	NULL
,	NULL
R.	NULL
Gentz	NULL
,	NULL
B.R	NULL
.	NULL

Franza	NULL
Jr.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
product	NULL
of	NULL
a	NULL
fos-related	NULL
gene	NULL
,	NULL
fra-1	NULL
,	NULL
binds	NULL
cooperatively	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
with	NULL
Jun	NULL
:	NULL
transcription	NULL
factor	NULL
AP-1	NULL
is	NULL
comprised	NULL
of	NULL
multiple	NULL
protein	NULL
complexes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3	NULL
;	NULL
173-184	NULL
.	NULL

Curran	NULL
,	NULL
T.	NULL
and	NULL
BR	NULL
.	NULL

Franza	NULL
J1	NULL
.	NULL

1988	NULL
.	NULL

Fos	NULL
and	NULL
Jun	NULL
:	NULL
The	NULL
AP-1	NULL
con-nection	NULL
.	NULL

Cell	NULL
55	NULL
;	NULL
395-397	NULL
.	NULL

Curtin	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
Pirastu	NULL
,	NULL
Y.W	NULL
.	NULL

Kan	NULL
,	NULL
J.A	NULL
.	NULL

Gobert-Jones	NULL
,	NULL
A.D.	NULL
Ste-phens	NULL
,	NULL
and	NULL
H.	NULL
Lehmann	NULL
.	NULL

1985	NULL
.	NULL

A	NULL
distant	NULL
gene	NULL
deletion	NULL
affects	NULL
B-globin	NULL
gene	NULL
function	NULL
in	NULL
an	NULL
atypical	NULL
y5B-thalassemia	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

761	NULL
1554-1558	NULL
.	NULL

Curtin	NULL
,	NULL
P.	NULL
,	NULL
D.	NULL
Lui	NULL
,	NULL
W.	NULL
Lui	NULL
,	NULL
J.	NULL
Chang	NULL
,	NULL
and	NULL
Y.W	NULL
.	NULL

Kan.	NULL
1989	NULL
.	NULL

Human	NULL
-globin	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
is	NULL
enhanced	NULL
by	NULL
a	NULL
distant	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

86	NULL
:	NULL
7082-7086	NULL
.	NULL

Dean	NULL
,	NULL
A.	NULL
,	NULL
TJ	NULL
.	NULL

Ley	NULL
,	NULL
RK	NULL
.	NULL

Humphries	NULL
,	NULL
M.	NULL
Fordis	NULL
,	NULL
and	NULL
A.N	NULL
.	NULL

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Schechter	NULL
.	NULL

1983	NULL
.	NULL

Inducible	NULL
transcription	NULL
of	NULL
five	NULL
globin	NULL
genes	NULL
in	NULL
K562	NULL
human	NULL
leukemia	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

80	NULL
:	NULL
5515-5519.	NULL
deBoer	NULL
,	NULL
E.	NULL
,	NULL
M.	NULL
Antoniou	NULL
,	NULL
V.	NULL
Mignotte	NULL
,	NULL
L.	NULL
Wall	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
promoter	NULL
;	NULL
nuclear	NULL
protein	NULL
factors	NULL
and	NULL
erythroid	NULL
specific	NULL
induction	NULL
of	NULL
transcription	NULL
.	NULL

EMBO	NULL
/	NULL
.	NULL

7	NULL
:	NULL
4203-4212.	NULL
deWet	NULL
,	NULL
JR.	NULL
,	NULL
KV	NULL
.	NULL

Wood	NULL
,	NULL
M.	NULL
Deluca	NULL
,	NULL
D.R	NULL
.	NULL

Helinski	NULL
,	NULL
and	NULL
S.	NULL
Su-bramani	NULL
.	NULL

1987	NULL
.	NULL

Firefly	NULL
luciferase	NULL
gene	NULL
:	NULL
Structure	NULL
and	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
:	NULL
725-737	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
R.M	NULL
.	NULL

Lebovitz	NULL
,	NULL
and	NULL
R.G	NULL
.	NULL

Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
;	NULL
1475-1489	NULL
.	NULL

Donovan-Peluso	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Acuto	NULL
,	NULL
M.	NULL
Swanson	NULL
,	NULL
C.	NULL
Dobkin	NULL
,	NULL
and	NULL
A	NULL
.	NULL

Bank	NULL
.	NULL

1987	NULL
.	NULL

Expression	NULL
of	NULL
human	NULL
y-globin	NULL
genes	NULL
in	NULL
human	NULL
erythroleukemia	NULL
(	NULL
K562	NULL
)	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
;	NULL
17051-17057	NULL
.	NULL

Driscoll	NULL
,	NULL
C.	NULL
,	NULL
C.S	NULL
.	NULL

Dobkin	NULL
,	NULL
and	NULL
B.P	NULL
.	NULL

Alter	NULL
.	NULL

1989	NULL
.	NULL

Gamma/delta/	NULL
beta	NULL
thalassemia	NULL
due	NULL
to	NULL
a	NULL
de	NULL
novo	NULL
mutation	NULL
deleting	NULL
the	NULL
5	NULL
'	NULL
B	NULL
globin	NULL
gene	NULL
locus	NULL
activating	NULL
region	NULL
hypersensitive	NULL
sites	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

86	NULL
;	NULL
7470-7474	NULL
.	NULL

Dynan	NULL
,	NULL
W.S	NULL
.	NULL

1989	NULL
.	NULL

Modularity	NULL
in	NULL
promoters	NULL
and	NULL
enhancers	NULL
.	NULL

Cell	NULL
58	NULL
:	NULL
1-4	NULL
.	NULL

Forrester	NULL
,	NULL
W.C.	NULL
,	NULL
U.	NULL
Novak	NULL
,	NULL
R.	NULL
Gelinas	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
locus	NULL
activation	NULL
region	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

86:5439-5443	NULL
.	NULL

Forrester	NULL
,	NULL
W.C.	NULL
,	NULL
S.	NULL
Takegawa	NULL
,	NULL
T.	NULL
Papayannopoulou	NULL
,	NULL
G.	NULL
Stamatoyannopoulos	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1987	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
locus	NULL
activation	NULL
region	NULL
:	NULL
The	NULL
formation	NULL
of	NULL
developmentally	NULL
stable	NULL
hypersensitive	NULL
sites	NULL
in	NULL
globin-expressing	NULL
hybrids	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
;	NULL
10159-10177	NULL
.	NULL

Forrester	NULL
,	NULL
W.C.	NULL
,	NULL
C.	NULL
Thompson	NULL
,	NULL
J.T	NULL
.	NULL

Elder	NULL
,	NULL
and	NULL
M.	NULL
Groudine	NULL
.	NULL

1986	NULL
.	NULL

A	NULL
developmentally	NULL
stable	NULL
chromatin	NULL
structure	NULL
in	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
cluster	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

83	NULL
:	NULL
1359-1363	NULL
.	NULL

Fried	NULL
,	NULL
M.	NULL
and	NULL
D.M	NULL
.	NULL

Crothers	NULL
.	NULL

1981	NULL
.	NULL

Equilibria	NULL
and	NULL
kinetics	NULL
of	NULL
lac	NULL
repressor-operator	NULL
interactions	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

9	NULL
:	NULL
6506-6525	NULL
.	NULL

Gentz	NULL
,	NULL
R.	NULL
,	NULL
FJ	NULL
.	NULL

Rauscher	NULL
III	NULL
,	NULL
C.	NULL
Abate	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1989	NULL
.	NULL

Parallel	NULL
association	NULL
of	NULL
fos	NULL
and	NULL
jun	NULL
leucine	NULL
zippers	NULL
juxtaposes	NULL
DNA	NULL
binding	NULL
domains	NULL
.	NULL

Science	NULL
243	NULL
:	NULL
1695-1699	NULL
.	NULL

Grosveld	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Blom	NULL
van	NULL
Assendelft	NULL
,	NULL
D.R	NULL
.	NULL

Greaves	NULL
,	NULL
and	NULL
G.	NULL
Kollias	NULL
.	NULL

1987	NULL
.	NULL

Position-independent	NULL
,	NULL
high-level	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Cell	NULL
51	NULL
:	NULL
975-985	NULL
.	NULL

Groudine	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Kohwi-Shigematsu	NULL
,	NULL
R.	NULL
Gelinas	NULL
,	NULL
G.	NULL
Stamatoyannopoulos	NULL
,	NULL
and	NULL
T.	NULL
Papayannopoulou	NULL
.	NULL

1983	NULL
.	NULL

Human	NULL
fetal	NULL
to	NULL
adult	NULL
hemoglobin	NULL
switching	NULL
:	NULL
Changes	NULL
in	NULL
chromatin	NULL
structure	NULL
of	NULL
the	NULL
B-globin	NULL
gene	NULL
locus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

80	NULL
:	NULL
7551-7555	NULL
.	NULL

Gumucio	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
KL	NULL
.	NULL

Rood	NULL
,	NULL
TA	NULL
.	NULL

Gray	NULL
,	NULL
MF	NULL
.	NULL

Riordan	NULL
,	NULL
C.L	NULL
.	NULL

Sartor	NULL
,	NULL
and	NULL
F.S	NULL
.	NULL

Collins	NULL
1988	NULL
.	NULL

Nuclear	NULL
proteins	NULL
that	NULL
bind	NULL
the	NULL
human	NULL
y-globin	NULL
gene	NULL
promoter	NULL
:	NULL
alterations	NULL
in	NULL
binding	NULL
produced	NULL
by	NULL
point	NULL
mutations	NULL
associated	NULL
with	NULL
hereditary	NULL
persistence	NULL
of	NULL
fetal	NULL
hemoglobin	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
:	NULL
5310-5322	NULL
.	NULL

Halazonetis	NULL
,	NULL
TD	NULL
.	NULL

,	NULL
K.	NULL
Georgopoulos	NULL
,	NULL
M.E	NULL
.	NULL

Greenberg	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1988.	NULL
c-Jun	NULL
dimerizes	NULL
with	NULL
itself	NULL
and	NULL
with	NULL
c-Fos	NULL
,	NULL
forming	NULL
complexes	NULL
of	NULL
different	NULL
DNA	NULL
binding	NULL
affinities	NULL
.	NULL

Cell	NULL
55	NULL
:	NULL
917-924	NULL
.	NULL

Hirai	NULL
,	NULL
SI	NULL
.	NULL

,	NULL
RP	NULL
.	NULL

Ryseck	NULL
,	NULL
F.	NULL
Mechta	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
M.	NULL
Yaniv	NULL
.	NULL

1989	NULL
.	NULL

Characterization	NULL
of	NULL
junD	NULL
:	NULL
A	NULL
new	NULL
member	NULL
of	NULL
the	NULL
jun	NULL
proto-oncogene	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8	NULL
:	NULL
1433-1439	NULL
.	NULL

Hoffman	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Ibrahim	NULL
,	NULL
M.J.	NULL
Murnane	NULL
,	NULL
A.	NULL
Diamond	NULL
,	NULL
B.G	NULL
.	NULL

Forget	NULL
,	NULL
and	NULL
R.D	NULL
.	NULL

Levere	NULL
.	NULL

1980	NULL
.	NULL

Hemin	NULL
control	NULL
of	NULL
heme	NULL
bio-synthesis	NULL
and	NULL
catabolism	NULL
in	NULL
a	NULL
human	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

AP-1	NULL
sites	NULL
in	NULL
DCR	NULL
function	NULL
as	NULL
inducible	NULL
enhancer	NULL
Blood	NULL
56	NULL
:	NULL
567-570	NULL
.	NULL

Jackson	NULL
,	NULL
P.D	NULL
.	NULL

,	NULL
T.	NULL
Evans	NULL
,	NULL
J.M	NULL
.	NULL

Nickol	NULL
,	NULL
and	NULL
G.	NULL
Felsenfeld	NULL
.	NULL

1989	NULL
.	NULL

Developmental	NULL
modulation	NULL
of	NULL
protein	NULL
binding	NULL
to	NULL
B-globin	NULL
gene	NULL
regulatory	NULL
sites	NULL
within	NULL
chicken	NULL
erythrocyte	NULL
nuclei	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3	NULL
;	NULL
1860-1873	NULL
.	NULL

Jones	NULL
,	NULL
K.A	NULL
.	NULL

,	NULL
K.R	NULL
.	NULL

Yamamoto	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1985	NULL
.	NULL

Two	NULL
distinct	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
HSV	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
42	NULL
:	NULL
559-572	NULL
.	NULL

Jones	NULL
,	NULL
N.C.	NULL
,	NULL
P.W	NULL
.	NULL

Rigby	NULL
,	NULL
and	NULL
E.B	NULL
.	NULL

Ziff	NULL
.	NULL

1988	NULL
.	NULL

Trans-acting	NULL
protein	NULL
factors	NULL
and	NULL
the	NULL
regulation	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
:	NULL
Lessons	NULL
from	NULL
studies	NULL
on	NULL
DNA	NULL
tumor	NULL
viruses	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2	NULL
:	NULL
267-281	NULL
.	NULL

Karlsson	NULL
,	NULL
S.	NULL
and	NULL
A.W	NULL
.	NULL

Nienhuis	NULL
.	NULL

1985	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
human	NULL
globin	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

54	NULL
:	NULL
1071-1108	NULL
.	NULL

Kioussis	NULL
,	NULL
D.	NULL
,	NULL
E.	NULL
Vanin	NULL
,	NULL
T.	NULL
delange	NULL
,	NULL
R.A.	NULL
Flavell	NULL
,	NULL
and	NULL
F.G.	NULL
Grosveld	NULL
.	NULL

1983	NULL
.	NULL

B-Globin	NULL
gene	NULL
inactivation	NULL
by	NULL
DNA	NULL
transloca-tion	NULL
in	NULL
yB-thalassemia	NULL
.	NULL

Nature	NULL
306	NULL
;	NULL
662-666	NULL
.	NULL

Kioussis	NULL
,	NULL
D.	NULL
,	NULL
F.	NULL
Wilson	NULL
,	NULL
K.	NULL
Khazaie	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1985	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
human	NULL
globin	NULL
genes	NULL
introduced	NULL
in	NULL
K562	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4	NULL
:	NULL
927-931	NULL
.	NULL

Kollias	NULL
,	NULL
G.	NULL
,	NULL
N.	NULL
Wrighton	NULL
,	NULL
J.	NULL
Hurst	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1986	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
human	NULL
*y	NULL
,	NULL
B-	NULL
,	NULL
and	NULL
hybrid	NULL
y	NULL
B-globin	NULL
genes	NULL
in	NULL
transgenic	NULL
mice	NULL
:	NULL
Manipulation	NULL
of	NULL
the	NULL
developmental	NULL
expression	NULL
patterns	NULL
.	NULL

Cell	NULL
46:89-94	NULL
.	NULL

Kollias	NULL
,	NULL
G.	NULL
,	NULL
J.	NULL
Hurst	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1987	NULL
.	NULL

The	NULL
human	NULL
betaglobin	NULL
gene	NULL
contains	NULL
a	NULL
downstream	NULL
developmental	NULL
specific	NULL
enhancer	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

15	NULL
:	NULL
5739-5747	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
and	NULL
E.	NULL
Ziff	NULL
.	NULL

1989	NULL
.	NULL

Leucine	NULL
zippers	NULL
of	NULL
fos	NULL
,	NULL
jun	NULL
and	NULL
GCN4	NULL
dictate	NULL
dimerization	NULL
specificity	NULL
and	NULL
thereby	NULL
control	NULL
DNA	NULL
binding	NULL
.	NULL

Nature	NULL
340	NULL
:	NULL
568-571	NULL
.	NULL

Kuwabara	NULL
,	NULL
M.D	NULL
.	NULL

and	NULL
D.S	NULL
.	NULL

Sigman	NULL
.	NULL

1987	NULL
.	NULL

Footprinting	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
situ	NULL
following	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
1,10-phenanthroline/copper	NULL
ion	NULL
:	NULL
Escherichia	NULL
coli	NULL
RNA	NULL
polymerase-lac	NULL
promoter	NULL
complexes	NULL
.	NULL

Biochemistry	NULL
26	NULL
:	NULL
7234-7238	NULL
.	NULL

Lee	NULL
,	NULL
W.	NULL
,	NULL
A.	NULL
Haslinger	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
transcription	NULL
by	NULL
two	NULL
factors	NULL
that	NULL
bind	NULL
promoter	NULL
and	NULL
enhancer	NULL
sequences	NULL
of	NULL
the	NULL
human	NULL
metallothionein	NULL
gene	NULL
and	NULL
SV40	NULL
.	NULL

Nature	NULL
325	NULL
:	NULL
368-372	NULL
.	NULL

Lin	NULL
,	NULL
HJ	NULL
.	NULL

,	NULL
N.P	NULL
.	NULL

Anagnou	NULL
,	NULL
TR	NULL
.	NULL

Rutherford	NULL
,	NULL
T.	NULL
Shimada	NULL
,	NULL
and	NULL
A.W	NULL
.	NULL

Nienhuis	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
promoter	NULL
in	NULL
K562	NULL
cells	NULL
by	NULL
DNA	NULL
sequences	NULL
5	NULL
)	NULL
to	NULL
the	NULL
fetal	NULL
y-	NULL
or	NULL
embryonic	NULL
{	NULL
-globin	NULL
genes	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

80	NULL
:	NULL
374-380	NULL
.	NULL

Lloyd	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
RF	NULL
.	NULL

Lee	NULL
,	NULL
and	NULL
J.B.	NULL
Lingrel	NULL
.	NULL

1989	NULL
.	NULL

Mutations	NULL
in	NULL
two	NULL
regions	NULL
upstream	NULL
of	NULL
the	NULL
Ay	NULL
globin	NULL
gene	NULL
canonical	NULL
promoter	NULL
affect	NULL
gene	NULL
expression	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
:	NULL
4339-4352	NULL
.	NULL

Lozzio	NULL
,	NULL
C.B	NULL
.	NULL

and	NULL
B.B	NULL
.	NULL

Lozzio	NULL
.	NULL

1975	NULL
.	NULL

Human	NULL
chronic	NULL
myeloge-nous	NULL
leukemia	NULL
cell-line	NULL
with	NULL
positive	NULL
Philadelphia	NULL
chromo-some	NULL
.	NULL

Blood	NULL
45	NULL
:	NULL
321-334	NULL
.	NULL

Magram	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Chada	NULL
,	NULL
and	NULL
F.	NULL
Costantini	NULL
,	NULL
.	NULL

1985	NULL
.	NULL

Developmental	NULL
regulation	NULL
of	NULL
a	NULL
cloned	NULL
adult	NULL
B-globin	NULL
gene	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Nature	NULL
315	NULL
:	NULL
338-340	NULL
.	NULL

Mantovani	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Malgaretti	NULL
,	NULL
S.	NULL
Nicolis	NULL
,	NULL
B.	NULL
Giglioni	NULL
,	NULL
P.	NULL
Comi	NULL
,	NULL
N.	NULL
Cappellini	NULL
,	NULL
M.T	NULL
.	NULL

Bertero	NULL
,	NULL
F.	NULL
Caligaris-Cappio	NULL
,	NULL
andd	NULL
S.	NULL
Ottolenghi	NULL
.	NULL

1988a	NULL
.	NULL

An	NULL
erythroid	NULL
specific	NULL
nuclear	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
proximal	NULL
CACCC	NULL
box	NULL
of	NULL
the	NULL
-globin	NULL
gene	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
:	NULL
4299-4313	NULL
.	NULL

Mantovani	NULL
,	NULL
R.	NULL
,	NULL
N.	NULL
Malgaretti	NULL
,	NULL
S.	NULL
Nicolis	NULL
,	NULL
A.	NULL
Ronchi	NULL
,	NULL
B.	NULL
Giglioni	NULL
,	NULL
and	NULL
S.	NULL
Ottolenghi	NULL
.	NULL

1988b	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
HPFH	NULL
mutations	NULL
in	NULL
the	NULL
human	NULL
gamma-globin	NULL
promoter	NULL
on	NULL
binding	NULL
of	NULL
ubiquitous	NULL
and	NULL
erythroid	NULL
specific	NULL
nuclear	NULL
factors	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
:	NULL
7783-7797	NULL
.	NULL

McGinniss	NULL
,	NULL
M.H	NULL
.	NULL

and	NULL
A	NULL
.	NULL

Dean	NULL
.	NULL

1985	NULL
.	NULL

Expression	NULL
of	NULL
red	NULL
cell	NULL
antigens	NULL
by	NULL
K562	NULL
human	NULL
leukemia	NULL
cells	NULL
before	NULL
and	NULL
after	NULL
in	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
1005	NULL
Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
Ney	NULL
et	NULL
al	NULL
.	NULL

duction	NULL
of	NULL
hemoglobin	NULL
synthesis	NULL
by	NULL
hemin	NULL
.	NULL

Transfusion	NULL
25	NULL
:	NULL
105-109	NULL
.	NULL

Mignotte	NULL
,	NULL
V.	NULL
,	NULL
J.F	NULL
.	NULL

Eleouet	NULL
,	NULL
N.	NULL
Raich	NULL
,	NULL
and	NULL
P.H	NULL
.	NULL

Romeo	NULL
.	NULL

19891	NULL
.	NULL

Cis-	NULL
and	NULL
transacting	NULL
elements	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
erythroid	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

86	NULL
:	NULL
6548-6552	NULL
.	NULL

Mignotte	NULL
,	NULL
V.	NULL
,	NULL
L.	NULL
Wall	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
P.H	NULL
.	NULL

Romeo	NULL
.	NULL

1989b	NULL
.	NULL

Two	NULL
tissue-specific	NULL
factors	NULL
bind	NULL
the	NULL
erythroid	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
porphobilinogen	NULL
deaminase	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
:	NULL
37-54	NULL
.	NULL

Mitchell	NULL
,	NULL
PJ	NULL
.	NULL

and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
in	NULL
mammalian	NULL
cells	NULL
by	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Science	NULL
245	NULL
:	NULL
371-378	NULL
.	NULL

Nelson	NULL
,	NULL
C.	NULL
,	NULL
V.R	NULL
.	NULL

Albert	NULL
,	NULL
HP	NULL
.	NULL

Elsholtz	NULL
,	NULL
LLW	NULL
.	NULL

Lu	NULL
,	NULL
and	NULL
M.G	NULL
.	NULL

Ro-senfeld	NULL
.	NULL

1988	NULL
.	NULL

Activation	NULL
of	NULL
cell-specific	NULL
expression	NULL
of	NULL
rat	NULL
growth	NULL
hormone	NULL
and	NULL
prolactin	NULL
genes	NULL
by	NULL
a	NULL
common	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
239	NULL
;	NULL
1400-1405	NULL
.	NULL

Neumann	NULL
,	NULL
JR.	NULL
,	NULL
C.A	NULL
.	NULL

Morency	NULL
,	NULL
and	NULL
K.O	NULL
.	NULL

Russian	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
novel	NULL
rapid	NULL
assay	NULL
for	NULL
chloramphenicol	NULL
acetyltransferase	NULL
gene	NULL
expression	NULL
.	NULL

BioTechniques	NULL
5	NULL
:	NULL
444-447	NULL
.	NULL

Pertovaara	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Sistonen	NULL
,	NULL
T.	NULL
]	NULL
.	NULL

Bos	NULL
,	NULL
P.K	NULL
.	NULL

Vogt	NULL
,	NULL
J.	NULL
Keski-Oja	NULL
,	NULL
and	NULL
K.	NULL
Alitalo	NULL
.	NULL

1989	NULL
.	NULL

Enhanced	NULL
jun	NULL
gene	NULL
expression	NULL
is	NULL
an	NULL
early	NULL
genomic	NULL
response	NULL
to	NULL
transforming	NULL
growth	NULL
factor	NULL
beta	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
:	NULL
1255-1262	NULL
.	NULL

Phelps	NULL
,	NULL
W.C.	NULL
and	NULL
P.M.	NULL
Howley	NULL
.	NULL

1987	NULL
.	NULL

Transcriptional	NULL
trans-ac-tivation	NULL
by	NULL
the	NULL
human	NULL
papillomavirus	NULL
type	NULL
16	NULL
E2	NULL
gene	NULL
product	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61	NULL
:	NULL
1630-1638	NULL
.	NULL

Potter	NULL
,	NULL
H.	NULL
,	NULL
L.	NULL
Weir	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1984	NULL
.	NULL

Enhancer-dependent	NULL
expression	NULL
of	NULL
human	NULL
k-immunoglobulin	NULL
genes	NULL
introduced	NULL
into	NULL
mouse	NULL
pre-B	NULL
lymphocytes	NULL
by	NULL
electroporation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

81	NULL
:	NULL
7161-7165	NULL
.	NULL

Ransone	NULL
,	NULL
LJ	NULL
.	NULL

,	NULL
J.	NULL
Visvader	NULL
,	NULL
P.	NULL
Sassone-Corsi	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

Verma	NULL
.	NULL

1989	NULL
.	NULL

Fos-jun	NULL
interaction	NULL
:	NULL
Mutational	NULL
analysis	NULL
of	NULL
the	NULL
leucine	NULL
zipper	NULL
domain	NULL
of	NULL
both	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3	NULL
:	NULL
770-781	NULL
.	NULL

Rauscher	NULL
,	NULL
F.J.	NULL
,	NULL
III	NULL
,	NULL
P.J	NULL
.	NULL

Voulalas	NULL
,	NULL
B.R	NULL
.	NULL

Franza	NULL
Jr.	NULL
,	NULL
and	NULL
T.	NULL
Curran	NULL
.	NULL

1988	NULL
.	NULL

Fos	NULL
and	NULL
jun	NULL
bind	NULL
cooperatively	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
:	NULL
Re-constitution	NULL
in	NULL
vitro	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2	NULL
:	NULL
1687-1699	NULL
.	NULL

Reitman	NULL
,	NULL
M.	NULL
and	NULL
G.	NULL
Felsenfeld	NULL
.	NULL

1988	NULL
,	NULL
Mutational	NULL
analysis	NULL
of	NULL
the	NULL
chicken	NULL
beta-globin	NULL
enhancer	NULL
reveals	NULL
two	NULL
positive-acting	NULL
domains	NULL
.	NULL

Proc	NULL
.	NULL

Nat	NULL
]	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

85	NULL
:	NULL
6267-6271	NULL
.	NULL

Rutherford	NULL
,	NULL
T.	NULL
and	NULL
A.W	NULL
.	NULL

Nienhuis	NULL
,	NULL
1987	NULL
.	NULL

Human	NULL
globin	NULL
gene	NULL
promoter	NULL
sequences	NULL
are	NULL
sufficient	NULL
for	NULL
specific	NULL
expression	NULL
of	NULL
a	NULL
hybrid	NULL
gene	NULL
transfected	NULL
into	NULL
tissue	NULL
culture	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
:	NULL
398-402	NULL
.	NULL

Rutherford	NULL
,	NULL
T.	NULL
,	NULL
J.B.	NULL
Clegg	NULL
,	NULL
D.R	NULL
.	NULL

Higgs	NULL
,	NULL
RW	NULL
.	NULL

Jones	NULL
,	NULL
J.	NULL
Thompson	NULL
,	NULL
and	NULL
D.J	NULL
.	NULL

Weatherall	NULL
.	NULL

1981	NULL
.	NULL

Embryonic	NULL
erythroid	NULL
differentiation	NULL
in	NULL
the	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
K562	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

78	NULL
:	NULL
348-352	NULL
.	NULL

Ryan	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
RR	NULL
.	NULL

Behringer	NULL
,	NULL
N.C.	NULL
Martin	NULL
,	NULL
TM	NULL
.	NULL

Townes	NULL
,	NULL
RD	NULL
.	NULL

Palmiter	NULL
,	NULL
and	NULL
R.L	NULL
.	NULL

Brinster	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
single	NULL
erythroid-specific	NULL
DNase	NULL
I	NULL
superhypersensitive	NULL
site	NULL
activates	NULL
high	NULL
levels	NULL
of	NULL
human	NULL
B-globin	NULL
gene	NULL
expression	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3	NULL
:	NULL
314-323	NULL
.	NULL

Smith	NULL
,	NULL
A.J.H	NULL
.	NULL

1980	NULL
.	NULL

DNA	NULL
sequence	NULL
analysis	NULL
by	NULL
primed	NULL
syn-thesis	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

65	NULL
:	NULL
560-580	NULL
.	NULL

Sorrentino	NULL
,	NULL
B.P	NULL
.	NULL

,	NULL
P.A	NULL
.	NULL

Ney	NULL
,	NULL
D.M	NULL
.	NULL

Bodine	NULL
,	NULL
and	NULL
A.W	NULL
.	NULL

Nienhuis	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
46	NULL
base	NULL
pair	NULL
enhancer	NULL
sequence	NULL
within	NULL
the	NULL
locus	NULL
activating	NULL
region	NULL
is	NULL
required	NULL
for	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
y-globin	NULL
gene	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

{	NULL
in	NULL
press	NULL
}	NULL
.	NULL

Stamatoyannopoulos	NULL
,	NULL
G.	NULL
and	NULL
A.W	NULL
.	NULL

Nienhuis	NULL
,	NULL
.	NULL

1987	NULL
.	NULL

Hemoglobin	NULL
switching	NULL
.	NULL

In	NULL
The	NULL
molecular	NULL
basis	NULL
of	NULL
blood	NULL
diseases	NULL
[	NULL
ed	NULL
.	NULL

G.	NULL
Stamatoyannopoulos	NULL
,	NULL
A.	NULL
Nienhuis	NULL
,	NULL
P.	NULL
Leder	NULL
,	NULL
and	NULL
P.	NULL
Majerus	NULL
)	NULL
,	NULL
pp	NULL
.	NULL

67-105	NULL
.	NULL

W.B	NULL
.	NULL

Saunders	NULL
,	NULL
Philadelphia	NULL
.	NULL

Strauss	NULL
,	NULL
F.	NULL
and	NULL
A.	NULL
Varshavsky	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
protein	NULL
binds	NULL
to	NULL
a	NULL
satel-	NULL
1006	NULL
GENES	NULL
&	NULL
DEVELOPMENT	NULL
lite	NULL
DNA	NULL
repeat	NULL
at	NULL
three	NULL
specific	NULL
sites	NULL
that	NULL
would	NULL
be	NULL
brought	NULL
into	NULL
mutual	NULL
proximity	NULL
by	NULL
DNA	NULL
folding	NULL
in	NULL
the	NULL
nucleosome	NULL
.	NULL

Cell	NULL
37	NULL
:	NULL
889-901	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
Collis	NULL
,	NULL
M.	NULL
Antoniou	NULL
,	NULL
M.	NULL
Vidal	NULL
,	NULL
F.	NULL
Grosveld	NULL
,	NULL
and	NULL
D.R	NULL
.	NULL

Greaves	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
dominant	NULL
control	NULL
region	NULL
from	NULL
the	NULL
human	NULL
-globin	NULL
locus	NULL
conferring	NULL
integration	NULL
site-indepen-dent	NULL
gene	NULL
expression	NULL
.	NULL

Nature	NULL
338	NULL
:	NULL
352-355	NULL
.	NULL

Townes	NULL
,	NULL
TM	NULL
.	NULL

,	NULL
J.B.	NULL
Lingrel	NULL
,	NULL
H.Y	NULL
.	NULL

Chen	NULL
,	NULL
RL	NULL
.	NULL

Brinster	NULL
,	NULL
and	NULL
R.D	NULL
.	NULL

Palmiter	NULL
.	NULL

1985	NULL
.	NULL

Erythroid-specific	NULL
expression	NULL
of	NULL
human	NULL
B-globin	NULL
genes	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

4	NULL
:	NULL
1715-1723	NULL
.	NULL

Trudel	NULL
,	NULL
M.	NULL
and	NULL
F.	NULL
Costantini	NULL
.	NULL

1987	NULL
.	NULL

A	NULL
3	NULL
'	NULL
enhancer	NULL
contributes	NULL
to	NULL
the	NULL
stage-specific	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
B-globin	NULL
gene	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1	NULL
:	NULL
954-961	NULL
.	NULL

Tsai	NULL
,	NULL
S.F	NULL
.	NULL

,	NULL
DA	NULL
.	NULL

Martin	NULL
,	NULL
LL	NULL
Zon	NULL
,	NULL
A.D.	NULL
D'Andrea	NULL
,	NULL
G.G	NULL
.	NULL

Wong	NULL
,	NULL
and	NULL
SH	NULL
.	NULL

Orkin	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
of	NULL
cDNA	NULL
for	NULL
the	NULL
major	NULL
DNA-binding	NULL
protein	NULL
of	NULL
the	NULL
erythroid	NULL
lineage	NULL
through	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nature	NULL
339:446-451	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
and	NULL
LM	NULL
.	NULL

London	NULL
.	NULL

1984	NULL
.	NULL

Mapping	NULL
of	NULL
DNAse	NULL
I-hyper-sensitive	NULL
sites	NULL
in	NULL
the	NULL
upstream	NULL
DNA	NULL
of	NULL
human	NULL
embryonic	NULL
epsilon-globin	NULL
gene	NULL
in	NULL
K562	NULL
leukemia	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

81	NULL
:	NULL
2718-2722	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
,	NULL
W.	NULL
Solomon	NULL
,	NULL
Q.	NULL
Li	NULL
,	NULL
and	NULL
LM	NULL
.	NULL

London	NULL
.	NULL

1985	NULL
.	NULL

The	NULL
``	NULL
B-like-globin	NULL
``	NULL
gene	NULL
domain	NULL
in	NULL
human	NULL
erythroid	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

82	NULL
;	NULL
6384-6388	NULL
.	NULL

Tuan	NULL
,	NULL
D.Y	NULL
.	NULL

,	NULL
W.B	NULL
.	NULL

Solomon	NULL
,	NULL
L.	NULL
M.	NULL
London	NULL
,	NULL
and	NULL
D.P	NULL
.	NULL

Lee	NULL
.	NULL

1989	NULL
.	NULL

An	NULL
erythroid-specific	NULL
,	NULL
-	NULL
developmental-stage-independent	NULL
-	NULL
enhancer	NULL
far	NULL
upstream	NULL
of	NULL
the	NULL
human	NULL
``	NULL
beta-like	NULL
globin	NULL
``	NULL
genes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

861	NULL
2554-2558	NULL
.	NULL

Turner	NULL
,	NULL
R.	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1989	NULL
.	NULL

Leucine	NULL
repeats	NULL
and	NULL
an	NULL
adjacent	NULL
DNA	NULL
binding	NULL
domain	NULL
mediate	NULL
the	NULL
formation	NULL
of	NULL
functional	NULL
cFos-cJun	NULL
heterodimers	NULL
.	NULL

Science	NULL
243	NULL
:	NULL
1689-1694	NULL
.	NULL

Wall	NULL
,	NULL
L.	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
human	NULL
B-globin	NULL
gene	NULL
3	NULL
'	NULL
enhancer	NULL
contains	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
an	NULL
erythroid-specific	NULL
protein	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

2	NULL
:	NULL
1089-1100	NULL
.	NULL

Wigler	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Pellicer	NULL
,	NULL
S.	NULL
Silverstein	NULL
,	NULL
and	NULL
R.	NULL
Axel	NULL
.	NULL

1978	NULL
.	NULL

Biochemical	NULL
transfer	NULL
of	NULL
single-copy	NULL
eucaryotic	NULL
genes	NULL
using	NULL
total	NULL
cellular	NULL
DNA	NULL
as	NULL
donor	NULL
.	NULL

Cell	NULL
14	NULL
:	NULL
725-731	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
,	NULL
E.	NULL
deBoer	NULL
,	NULL
FG	NULL
.	NULL

Grosveld	NULL
,	NULL
and	NULL
R.A.	NULL
Flavell	NULL
1983	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
family	NULL
in	NULL
murine	NULL
erythroleukaemia	NULL
cells	NULL
.	NULL

Nature	NULL
305	NULL
:	NULL
333-336	NULL
.	NULL

Wright	NULL
,	NULL
S.	NULL
,	NULL
A.	NULL
Rosenthal	NULL
,	NULL
R.	NULL
Flavell	NULL
,	NULL
and	NULL
F.	NULL
Grosveld	NULL
.	NULL

1984	NULL
.	NULL

DNA	NULL
sequences	NULL
required	NULL
for	NULL
regulated	NULL
expression	NULL
of	NULL
B-globin	NULL
genes	NULL
in	NULL
murine	NULL
erythroleukemia	NULL
cells	NULL
.	NULL

Cel	NULL
]	NULL
38	NULL
:	NULL
265-273	NULL
.	NULL

Downloaded	NULL
from	NULL
genesdev.cshlp.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
-	NULL
Published	NULL
by	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL
>	NULL
t	NULL
N-t	NULL
$	NULL
&	NULL
Development	NULL
Tandem	NULL
AP-1-binding	NULL
sites	NULL
within	NULL
the	NULL
human	NULL
beta-globin	NULL
dominant	NULL
control	NULL
region	NULL
function	NULL
as	NULL
an	NULL
inducible	NULL
enhancer	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

P	NULL
A	NULL
Ney	NULL
,	NULL
B	NULL
P	NULL
Sorrentino	NULL
,	NULL
K	NULL
T	NULL
McDonagh	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

1990	NULL
,	NULL
4	NULL
:	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
at	NULL
doi:10.1101/gad.4.6.993	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
81	NULL
articles	NULL
,	NULL
36	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
/genesdev.cshlp.org/content/4/6/993.full.html	NULL
#	NULL
ref-list-1	NULL
License	NULL
Email	NULL
Alerting	NULL
_	NULL
Receive	NULL
free	NULL
email	NULL
alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
-	NULL
sign	NULL
up	NULL
in	NULL
the	NULL
box	NULL
at	NULL
the	NULL
top	NULL
Service	NULL
-	NULL
``	NULL
ight	NULL
corner	NULL
of	NULL
the	NULL
article	NULL
or	NULL
click	NULL
here	NULL
.	NULL

CRISPR	NULL
KO	NULL
,	NULL
CRISPRa	NULL
,	NULL
CRISPRi	NULL
libraries	NULL
.	NULL

VIEW	NULL
PRODUCTS	NULL
>	NULL
CELLECTA	NULL
Custom	NULL
or	NULL
genome-wide	NULL
.	NULL

Copyright	NULL
©	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
Press	NULL

